Sarcopenic obesity or obese sarcopenia: A cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis

Ageing Research Reviews

Volumn 35, Issue , 2017, Pages 200-221

  Kalinkovich, Alexander ^a   Livshits, Gregory ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Adipose tissue; Age; Inflammation; Obesity; Sarcopenia; Sarcopenic obesity; Skeletal muscle

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; BONE MORPHOGENETIC PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CHEMERIN; CHEMOKINE; FIBROBLAST GROWTH FACTOR 21; FOLLISTATIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN 15; IRISIN; LEPTIN; MYOSTATIN; OSTEOPONTIN; PIGMENT EPITHELIUM DERIVED FACTOR; REACTIVE OXYGEN METABOLITE; RESISTIN;

ADIPOCYTE; ADIPOSE TISSUE; AGE; AUTOCRINE EFFECT; CELL ACTIVATION; CELL HYPERPLASIA; CYTOKINE RELEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EPIGENETICS; FATTY ACID OXIDATION; HUMAN; HYPERTROPHY; IMMUNOCOMPETENT CELL; INFLAMMATION; INSULIN RESISTANCE; LIPID METABOLISM; LIPID STORAGE; LIPOTOXICITY; MACROPHAGE; MUSCLE MASS; MUSCLE METABOLISM; MYOSITIS; NONHUMAN; PARACRINE SIGNALING; PATHOGENESIS; REVIEW; SARCOPENIC OBESITY; SENESCENCE; SENESCENCE ASSOCIATED SECRETORY PHENOTYPE; SKELETAL MUSCLE; AGING; CELL AGING; COMPLICATION; IMMUNOLOGY; METABOLISM; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SARCOPENIA;

ADIPOSE TISSUE; AGING; CELL AGING; HUMANS; INFLAMMATION; MUSCLE, SKELETAL; OBESITY; SARCOPENIA;

EID: 85005801887     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2016.09.008     Document Type: Review

References (416)

1. Acosta, J.C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J.P., Athineos, D., Kang, T.W., Lasitschka, F., Andrulis, M., Pascual, G., Morris, K.J., Khan, S., Jin, H., Dharmalingam, G., Snijders, A.P., Carroll, T., Capper, D., Pritchard, C., Inman, G.J., Longerich, T., Sansom, O.J., Benitah, S.A., Zender, L., Gil, J., A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat. Cell Biol. 15 (2013), 978–990.
2. Adams, J.M., Pratipanawatr, T., Berria, R., Wand, E., DeFronzo, R.A., Sullards, M.C., Mandarino, L.J., Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 53 (2004), 25–31.
3. Addison, O., Marcus, R.L., Lastayo, P.C., Ryan, A.S., Intermuscular fat: a review of the consequences and causes. Int. J. Endocrinol., 2014, 2014, 309570.
4. Ahl, S., Guenther, M., Zhao, S., James, R., Marks, J., Szabo, A., Kidambi, S., Adiponectin levels differentiate metabolically healthy vs unhealthy among obese and nonobese white individuals. J. Clin. Endocrinol. Metab. 100 (2015), 4172–4180.
5. Akhmedov, D., Berdeaux, R., The effects of obesity on skeletal muscle regeneration. Front. Physiol., 4, 2013, 371.
6. Allison, D.B., Zannolli, R., Faith, M.S., Heo, M., Pietrobelli, A., VanItallie, T.B., Pi-Sunyer, F.X., Heymsfield, S.B., Weight loss increases and fat loss decreases all-cause mortality rate: results from two independent cohort studies. Int. J. Obes. Relat. Metab. Disord. 23 (1999), 603–611.
7. Allott, E.H., Hursting, S.D., Obesity and cancer: mechanistic insights from transdisciplinary studies. Endocr. Relat. Cancer 22 (2015), R365–386.
8. Almendro, V., Fuster, G., Ametller, E., Costelli, P., Pilla, F., Busquetsm, S., Figueras, M., Argilés, J.M., López-Soriano, F.J., Interleukin-15 increases calcineurin expression in 3T3-L1 cells: possible involvement on in vivo adipocyte differentiation. Int. J. Mol. Med. 24 (2009), 453–458.
9. Alvarez, B., Carbo, N., Lopez-Soriano, J., Drivdahl, R.H., Busquets, S., Lopez-Soriano, F.J., Argiles, J.M., Quinn, L.S., Effects of interleukin-15 (IL-15) on adipose tissue mass in rodent obesity models: evidence for direct IL-15 action on adipose tissue. Biochim. Biophys. Acta 1570 (2002), 33–37.
10. Andersen, C.J., Murphy, K.E., Fernandez, M.L., Impact of obesity and metabolic syndrome on immunity. Adv. Nutr. 7 (2016), 66–75.
11. Aon, M.A., Bhatt, N., Cortassa, S.C., Mitochondrial and cellular mechanisms for managing lipid excess. Front. Physiol., 5, 2014, 282.
12. Apostolopoulos, V., de Courten, M.P., Stojanovska, L., Blatch, G.L., Tangalakis, K., de Courten, B., The complex immunological and inflammatory network of adipose tissue in obesity. Mol. Nutr. Food Res. 60 (2016), 43–57.
13. Arner, P., Kulyté, A., MicroRNA regulatory networks in human adipose tissue and obesity. Nat. Rev. Endocrinol. 11 (2015), 276–288.
14. Badin, P.M., Langin, D., Moro, C., Dynamics of skeletal muscle lipid pools. Trends Endocrinol. Metab. 24 (2013), 607–615.
15. Badoud, F., Perreault, M., Zulyniak, M.A., Mutch, D.M., Molecular insights into the role of white adipose tissue in metabolically unhealthy normal weight and metabolically healthy obese individuals. FASEB J. 29 (2015), 748–758.
16. Baker, D.J., Wijshake, T., Tchkonia, T., LeBrasseur, N.K., Childs, B.G., van de Sluis, B., Kirkland, J.L., van Deursen, J.M., Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479 (2011), 232–236.
17. Baker, D.J., Childs, B.G., Durik, M., Wijers, M.E., Sieben, C.J., Zhong, J., Saltness, R.A., Jeganathan, K.B., Verzosa, G.C., Pezeshki, A., Khazaie, K., Miller, J.D., van Deursen, J.M., Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature 530 (2016), 184–189.
18. Balsan, G.A., Vieira, J.L., Oliveira, A.M., Portal, V.L., Relationship between adiponectin, obesity and insulin resistance. Rev. Assoc. Med. Bras. 61 (2015), 72–80.
19. Barra, N.G., Chew, M.V., Reid, S., Ashkar, A.A., Interleukin-15 treatment induces weight loss independent of lymphocytes. PLoS One, 7, 2012, e39553.
20. Batsis, J.A., Barre, L.K., Mackenzie, T.A., Pratt, S.I., Lopez-Jimenez, F., Bartels, S.J., Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy x-ray absorptiometry data from the National Health and Nutrition Examination Survey 1999–2004. J. Am. Geriatr. Soc. 61 (2013), 974–980.
21. Batsis, J.A., Mackenzie, T.A., Lopez-Jimenez, F., Bartels, S.J., Sarcopenia, sarcopenic obesity, and functional impairments in older adults: National Health and Nutrition Examination Surveys 1999–2004. Nutr. Res. 35 (2015), 1031–1039.
22. Baudet, C., Pozas, E., Adameyko, I., Andersson, E., Ericson, J., Ernfors, P., Retrograde signaling onto Ret during motor nerve terminal maturation. J. Neurosci. 28 (2008), 963–975.
23. Baumgartner, R.N., Body composition in healthy aging. Ann. N. Y. Acad. Sci. 904 (2000), 437–448.
24. Beaudart, C., Rizzolim, R., Bruyère, O., Reginster, J.Y., Biver, E., Sarcopenia: burden and challenges for public health. Arch. Public Health, 72, 2014, 45.
25. Becerra, S.P., Structure-function studies on PEDF: a noninhibitory serpin with neurotrophic activity. Adv. Exp. Med. Biol. 425 (1997), 223–237.
26. Beenakker, K.G., Westendorp, R.G., de Craen, A.J., Slagboom, P.E., van Heemst, D., Maier, A.B., Pro-inflammatory capacity of classically activated monocytes relates positively to muscle mass and strength. Aging Cell 2 (2013), 682–689.
27. Bergman, B.C., Hunerdosse, D.M., Kerege, A., Playdon, M.C., Perreault, L., Localisation and composition of skeletal muscle diacylglycerol predicts insulin resistance in humans. Diabetologia 55 (2012), 1140–1150.
28. Berg, V., Sveinbjörnsson, B., Bendiksen, S., Brox, J., Meknas, K., Figenschau, Y., Human articular chondrocytes express ChemR23 and chemerin; ChemR23 promotes inflammatory signalling upon binding the ligand chemerin (21–157). Arthritis Res. Ther., 12, 2010 R228.
29. Berti, L., Irmler, M., Zdichavsky, M., Meile, T., Böhm, A., Stefan, N., Fritsche, A., Beckers, J., Königsrainer, A., Häring, H.U., de Angelis, M.H., Staiger, H., Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes. Mol. Metab. 4 (2015), 519–527.
30. Beyer, I., Mets, T., Bautmans, I., Chronic low- grade inflammation and age-related sarcopenia. Curr. Opin. Clin. Nutr. Metab. Care 15 (2012), 12–22.
31. Bing, C., Is interleukin-1β a culprit in macrophage-adipocyte crosstalk in obesity?. Adipocyte 4 (2015), 149–152.
32. Biolo, G., Cederholm, T., Muscaritoli, M., Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia. Clin. Nutr. 33 (2014), 737–748.
33. Bischoff, S.C., Microbiota and aging. Curr. Opin. Clin. Nutr. Metab. Care. 19 (2016), 26–30.
34. Blüher, M., Mantzoros, C.S., From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century. Metabolism 64 (2015), 131–145.
35. Blüher, S., Schwarz, P., Metabolically healthy obesity from childhood to adulthood – does weight status alone matter?. Metabolism 63 (2014), 1084–1092.
36. Blau, H.M., Cosgrove, B.D., Ho, A.T., The central role of muscle stem cells in regenerative failure with aging. Nat. Med. 21 (2015), 854–862.
37. Blundell, J.E., Dulloo, A.G., Salvador, J., Frühbeck, G., Beyond BMI-phenotyping the obesities. Obes. Facts 7 (2014), 322–328.
38. Boden, G., Obesity, insulin resistance and free fatty acids. Curr. Opin. Endocrinol. Diabetes Obes. 18 (2011), 139–143.
39. Bokarewa, M., Nagaev, I., Dahlberg, L., Smith, U., Tarkowski, A., Resistin, an adipokine with potent proinflammatory properties. J. Immunol. 174 (2005), 5789–5795.
40. Bosello, O., Donataccio, M.P., Cuzzolaro, M., Obesity or obesities? Controversies on the association between body mass index and premature mortality. Eat. Weight Disord. 21 (2016), 165–174.
41. Bosma, M., Lipid droplet dynamics in skeletal muscle. Exp. Cell Res. 340 (2016), 180–186.
42. Bosma, M., Kersten, S., Hesselink, M.K., Schrauwen, P., Re-evaluating lipotoxic triggers in skeletal muscle: relating intramyocellular lipid metabolism to insulin sensitivity. Prog. Lipid Res. 51 (2012), 36–49.
43. Bosma, M., Sparks, L.M., Hooiveld, G.J., Jorgensen, J.A., Houten, S.M., Schrauwen, P., Kersten, S., Hesselink, M.K., Overexpression of PLIN5 in skeletal muscle promotes oxidative gene expression and intramyocellular lipid content without compromising insulin sensitivity. Biochim. Biophys. Acta 1831 (2013), 844–852.
44. Boström, P., Wu, J., Jedrychowski, M.P., Korde, A., Ye, L., Lo, J.C., Rasbach, K.A., Boström, E.A., Choi, J.H., Long, J.Z., Kajimura, S., Zingaretti, M.C., Vind, B.F., Tu, H., Cinti, S., Højlund, K., Gygi, S.P., Spiegelman, B.M., A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481 (2012), 463–468.
45. Bouchard, D.R., Dionne, I.J., Brochu, M., Sarcopenic obesity and physical capacity in older men and women: data from the nutrition as a determinant of successful aging (Nu-Age)—the Quebec longitudinal study. Obesity 17 (2009), 2082–2088.
46. Boura-Halfon, S., Zick, Y., Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 296 (2009), E581–E591.
47. Bowser, M., Herberg, S., Arounleut, P., Shi, X., Fulzele, S., Hill, W.D., Isalesm, C.M., Hamrick, M.W., Effects of the activin A-myostatin-follistatin system on aging bone and muscle progenitor cells. Exp. Gerontol. 48 (2013), 290–297.
48. Bozaoglu, K., Curran, J.E., Stocker, C.J., Zaibi, M.S., Segal, D., Konstantopoulos, N., Morrison, S., Carless, M., Dyer, T.D., Cole, S.A., Goring, H.H., Moses, E.K., Walder, K., Cawthorne, M.A., Blangero, J., Jowett, J.B., Chemerin, a novel adipokine in the regulation of angiogenesis. J. Clin. Endocrinol. Metab. 95 (2010), 2476–2485.
49. Brestoff, J.R., Artis, D., Immune regulation of metabolic homeostasis in health and disease. Cell 161 (2015), 146–160.
50. Bruce, C.R., Anderson, M.J., Carey, A.L., Newman, D.G., Bonen, A., Kriketos, A.D., Cooney, G.J., Hawley, J.A., Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status. J. Clin. Endocrinol. Metab. 88 (2003), 5444–5451.
51. Buch, A., Carmeli, E., Boker, L.K., Marcus, Y., Shefer, G., Kis, O., Berner, Y., Stern, N., Muscle function and fat content in relation to sarcopenia: obesity and frailty of old age – an overview. Exp. Gerontol. 76 (2016), 25–32.
52. Budui, S.L., Rossi, A.P., Zamboni, M., The pathogenetic bases of sarcopenia. Clin. Cases Miner. Bone Metab. 12 (2015), 22–26.
53. Calay, E.S., Hotamisligil, G.S., Turning off the inflammatory, but not the metabolic, flames. Nat. Med. 19 (2013), 265–267.
54. Cantor, H., Shinohara, M.L., Regulation of T-helper-cell lineage development by osteopontin: the inside story. Nat. Rev. Immunol. 9 (2009), 137–141.
55. Carey, A.L., Petersen, E.W., Bruce, C.R., Southgate, R.J., Pilegaard, H., Hawley, J.A., Pedersen, B.K., Febbraio, M.A., Discordant gene expression in skeletal muscle and adipose tissue of patients with type 2 diabetes: effect of interleukin-6 infusion. Diabetologia 49 (2006), 1000–1007.
56. Carnagarin, R., Dharmarajan, A.M., Dass, C.R., PEDF attenuates insulin-dependent molecular pathways of glucose homeostasis in skeletal myocytes. Mol. Cell. Endocrinol. 422 (2016), 115–124.
57. Carolan, E., Tobin, L.M., Mangan, B.A., Corrigan, M., Gaoatswe, G., Byrne, G., Geoghegan, J., Cody, D., O'Connell, J., Winter, D.C., Doherty, D.G., Lynch, L., O'Shea, D., Hogan, A.E., Altered distribution and increased IL-17 production by mucosal-associated invariant T cells in adult and childhood obesity. J. Immunol. 194 (2015), 5580–5775.
58. Carter, H.N., Chen, C.C., Hood, D.A., Mitochondria, muscle health, and exercise with advancing age. Physiology (Bethesda) 30 (2015), 208–223.
59. Casazza, K., Pate, R., Allison, D.B., Myths, presumptions, and facts about obesity. N. Engl. J. Med. 368 (2013), 2236–2237.
60. Castoldi, A., Naffah de Souza, C., Câmara, N.O., Moraes-Vieira, P.M., The macrophage switch in obesity development. Front. Immunol., 6, 2016, 637.
61. Cauley, J.A., An overview of sarcopenic obesity. J. Clin. Densitom. 18 (2015), 499–505.
62. Cesari, M., Landi, F., Vellas, B., Bernabei, R., Marzetti, E., Sarcopenia and physical frailty: two sides of the same coin. Front. Aging Neurosci., 6, 2014, 192.
63. Chakraborti, C.K., New-found link between microbiota and obesity. World J. Gastrointest. Pathophysiol. 6 (2015), 110–119.
64. Chakaroun, R., Raschpichler, M., Klöting, N., Oberbach, A., Flehmig, G., Kern, M., Schön, M.R., Shang, E., Lohmann, T., Dreßler, M., Fasshauer, M., Stumvoll, M., Blüher, M., Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. Metabolism 61 (2012), 706–714.
65. Chan, A., Yan, J., Csurhes, P., Greer, J., McCombe, P., Circulating brain derived neurotrophic factor (BDNF) and frequency of BDNF positive T cells in peripheral blood in human ischemic stroke: effect on outcome. J. Neuroimmunol. 286 (2015), 42–47.
66. Chan, C.B., Tse, M.C., Liu, X., Zhang, S., Schmidt, R., Otten, R., Liu, L., Ye, K., Activation of muscular TrkB by its small molecular agonist 7,8-dihydroxyflavone sex-dependently regulates energy metabolism in diet-induced obese mice. Chem. Biol. 22 (2015), 355–368.
67. Chang, D.C., Piaggi, P., Hanson, R.L., Knowler, W.C., Bucci, J., Thio, G., Hohenadel, M.G., Bogardus, C., Krakoff, J., Use of a high-density protein microarray to identify autoantibodies in subjects with type 2 diabetes mellitus and an HLA background associated with reduced insulin secretion. PLoS One, 10, 2015, e0143551.
68. Chapman, J., Miles, P.D., Ofrecio, J.M., Neels, J.G., Yu, J.G., Resnik, J.L., Wilkes, J., Talukdar, S., Thapar, D., Johnson, K., Sears, D.D., Osteopontin is required for the early onset of high fat diet-induced insulin resistance in mice. PLoS One, 5, 2010, e13959.
69. Chavan, S.S., Hudson, L.K., Li, J.H., Ochani, M., Harris, Y., Patel, N.B., Katz, D., Scheinerman, J.A., Pavlov, V.A., Tracey, K.J., Identification of pigment epithelium-derived factor as an adipocyte-derived inflammatory factor. Mol. Med. 18 (2012), 1161–1168.
70. Chen, M.B., McAinch, A.J., Macaulay, S.L., Castelli, L.A., O'Brien, P.E., Dixon, J.B., Cameron-Smith, D., Kemp, B.E., Steinberg, G.R., Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics. J. Clin. Endocrinol. Metab. 90 (2005), 3665–3672.
71. Chen, L., Chen, R., Wang, H., Liang, F., Mechanisms linking inflammation to insulin resistance. Int. J. Endocrinol., 2015, 2015, 508409.
72. Chng, M.H., Alonso, M.N., Barnes, S.E., Nguyen, K.D., Engleman, E.G., Adaptive immunity and antigen-specific activation in obesity-associated insulin resistance. Mediators Inflamm., 2015, 2015, 593075.
73. Chung, C., Doll, J.A., Gattu, A.K., Shugrue, C., Cornwell, M., Fitchev, P., Crawford, S.E., Anti-angiogenic pigment epithelium-derived factor regulates hepatocyte triglyceride content through adipose triglyceride lipase (ATGL). J. Hepatol. 48 (2008), 471–478.
74. Chung, J.H., Hwang, H.J., Shin, H.Y., Han, C.H., Association between sarcopenic obesity and bone mineral density in middle-aged and elderly korean. Ann. Nutr. Metab. 68 (2016), 77–84.
75. Claflin, D.R., Jackson, M.J., Brooks, S.V., Age affects the contraction-induced mitochondrial redox response in skeletal muscle. Front. Physiol., 6, 2015, 21.
76. Cleasby, M.E., Jamieson, P., Atherton, P.J., Insulin resistance and sarcopenia: mechanistic links between common co-morbidities. J. Endocrinol.(March (1)), 2016.
77. Coen, P.M., Goodpaster, B.H., Role of intramyocelluar lipids in human health. Trends. Endocrinol. Metab. 23 (2012), 391–398.
78. Coimbra, S., Brandão Proença, J., Santos-Silva, A., Neuparth, M.J., Adiponectin, leptin, and chemerin in elderly patients with type 2 diabetes mellitus: a close linkage with obesity and length of the disease. Biomed. Res. Int., 2014, 2014, 701915.
79. Colombo, E., Bedogni, F., Lorenzetti, I., Landsberger, N., Previtali, S.C., Farina, C., Autocrine and immune cell-derived BDNF in human skeletal muscle: implications for myogenesis and tissue regeneration. J. Pathol. 231 (2013), 190–198.
80. Conte, M., Vasuri, F., Trisolino, G., Bellavista, E., Santoro, A., Degiovanni, A., Martucci, E., D'Errico Grigioni, A., Caporossi, D., Capri, M., Maier, A.B., Seynnes, O., Barberi, L., Musaro’, A., Narici, M.V., Franceschi, C., Salvioli, S., Increased Plin2 expression in human skeletal muscle is associated with sarcopenia and muscle weakness. PLoS One, 8, 2013, e73709.
81. Conte, M., Vasuri, F., Bertaggia, E., Armani, A., Santoro, A., Bellavista, E., Degiovanni, A., D'Errico-Grigioni, A., Trisolino, G., Capri, M., Franchi, M.V., Narici, M.V., Sandri, M., Franceschi, C., Salvioli, S., Differential expression of perilipin 2and 5 in human skeletal muscle during aging and their association withatrophy-related genes. Biogerontology, 16, 2015, 341.
82. Corcoran, M.P., Lamon-Fava, S., Fielding, R.A., Skeletal muscle lipid deposition and insulin resistance: effect of dietary fatty acids and exercise. Am. J. Clin. Nutr. 85 (2007), 662–677.
83. Coskun, T., Bina, H.A., Schneider, M.A., Dunbar, J.D., Hu, C.C., Chen, Y., Moller, D.E., Kharitonenkov, A., Fibroblast growth factor 21 corrects obesity in mice. Endocrinology 149 (2008), 6018–6027.
84. Craword, S.E., Fitchev, P., Veliceasa, D., Volpert, O.V., The many facets of PEDF in drug discovery and disease: a diamond in the rough or split personality disorder?. Expert Opin. Drug Discov. 8 (2013), 769–792.
85. Crescioli, C., Sottili, M., Bonini, P., Cosmi, L., Chiarugi, P., Romagnani, P., Vannelli, G.B., Colletti, M., Isidori, A.M., Serio, M., Lenzi, A., Di Luigi, L., Inflammatory response in human skeletal muscle cells: CXCL10 as a potential therapeutic target. Eur. J. Cell. Biol. 91 (2012), 139–149.
86. Crowe, S., Wu, L.E., Economou, C., Turpin, S.M., Matzaris, M., Hoehn, K.L., Hevener, A.L., James, D.E., Duh, E.J., Watt, M.J., Pigment epithelium-derived factor contributes to insulin resistance in obesity. Cell. Metab. 10 (2009), 40–47.
87. Cruz-Jentoft, A.J., Landi, F., Schneider, S.M., Zú̃niga, C., Arai, H., Boirie, Y., Chen, L.K., Fielding, R.A., Martin, F.C., Michel, J.P., Sieber, C., Stout, J.R., Studenski, S.A., Vellas, B., Woo, J., Zamboni, M., Cederholm, T., Prevalence of and interventions for sarcopenia in ageing adults: a systematic review: report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 43 (2014), 748–759.
88. Dalmas, E., Venteclef, N., Caer, C., Poitou, C., Cremer, I., Aron-Wisnewsky, J., Lacroix-Desmazes, S., Bayry, J., Kaveri, S.V., Clément, K., André, S., Guerre-Millo, M., T cell-derived IL-22 amplifies IL-1β-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes. Diabetes 63 (2014), 1966–1977.
89. Dam, T.T., Peters, K.W., Fragala, M., Cawthon, P.M., Harris, T.B., McLean, R., Shardell, M., Alley, D.E., Kenny, A., Ferrucci, L., Guralnik, J., Kiel, D.P., Kritchevsky, S., Vassileva, M.T., Studenski, S., An evidence-based comparison of operational criteria for the presence of sarcopenia. J. Gerontol. A: Biol. Sci. Med. Sci. 69 (2014), 584–590.
90. Daniele, G., Guardado Mendoza, R., Winnier, D., Fiorentino, T.V., Pengou, Z., Cornell, J., Andreozzi, F., Jenkinson, C., Cersosimo, E., Federici, M., Tripathy, D., Folli, F., The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus. Acta Diabetol. 51 (2014), 123–131.
91. DeFuria, J., Belkina, A.C., Jagannathan-Bogdan, M., Snyder-Cappione, J., Carr, J.D., Nersesova, Y.R., Markham, D., Strissel, K.J., Watkins, A.A., Zhu, M., Allen, J., Bouchard, J., Toraldo, G., Jasuja, R., Obin, M.S., McDonnell, M.E., Apovian, C., Denis, G.V., Nikolajczyk, B.S., B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 5133–5138.
92. Dela, F., Helge, J.W., Insulin resistance and mitochondrial function in skeletal muscle. Int. J. Biochem. Cell Biol. 45 (2013), 11–15.
93. Delmonico, M.J., Harris, T.B., Visser, M., Park, S.W., Conroy, M.B., Velasquez-Mieyer, P., Boudreau, R., Manini, T.M., Nevitt, M., Newman, A.B., Goodpaster, B.H., Health, Aging, and Body. Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am. J. Clin. Nutr. 90 (2009), 1579–1585.
94. Deshmukh, A.S., Cox, J., Jensen, L.J., Meissner, F., Mann, M., Secretome analysis of lipid-Induced insulin resistance in skeletal muscle cells by a combined experimental and bioinformatics workflow. J. Proteome Res. 14 (2015), 4885–4895.
95. DiSpirito, J.R., Mathis, D., Immunological contributions to adipose tissue homeostasis. Semin. Immunol. 27 (2015), 315–321.
96. Divoux, A., Moutel, S., Poitou, C., Lacasa, D., Veyrie, N., Aissat, A., Arock, M., Guerre-Millo, M., Clément, K., Mast cells in human adipose tissue: link with morbid obesity, inflammatory status, and diabetes. J. Clin. Endocrinol. Metab. 97 (2012), E1677–1685.
97. Dominguez, L.J., Barbagallo, M., The cardiometabolic syndrome and sarcopenic obesity in older persons. J. Cardiometab. Syndr. 2 (2007), 183–189.
98. Dong, J., Dong, Y., Dong, Y., Chen, F., Mitch, W.E., Zhang, L., Inhibition of myostatin in mice improves insulin sensitivity via irisin-mediated cross talk between muscle and adipose tissues. Int. J. Obes. (Lond.) 40 (2016), 434–442.
99. Doumatey, A.P., Zhou, J., Zhou, M., Prieto, D., Rotimi, C.N., Adeyemo, A., Proinflammatory and lipid biomarkers mediate metabolically healthy obesity: a proteomics study. Obesity (Silver Spring) 24 (2016), 1257–1265.
100. Duggan, C., Tapsoba, J.D., Wang, C.Y., McTiernan, A., Dietary weight loss and exercise effects on serum biomarkers of angiogenesis in overweight postmenopausal women: a randomized controlled trial. Cancer Res.(July (14)), 2016.
101. Eckel, N., Meidtner, K., Kalle-Uhlmann, T., Stefan, N., Schulze, M.B., Metabolically healthy obesity and cardiovascular events: a systematic review and meta-analysis. Eur. J. Prev. Cardiol. 23 (2016), 956–966.
102. Eljaafari, A., Robert, M., Chehimi, M., Chanon, S., Durand, C., Vial, G., Bendridi, N., Madec, A.M., Disse, E., Laville, M., Rieusset, J., Lefai, E., Vidal, H., Pirola, L., Adipose tissue-derived stem cells from obese subjects contribute to inflammation and reduced insulin response in adipocytes through differential regulation of the Th1/Th17 balance and monocyte activation. Diabetes 64 (2015), 2477–2488 Endocrinology 149, 2015, 6018–6027.
103. Esser, N., Legrand-Poels, S., Piette, J., Scheen, A.J., Paquot, N., Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res. Clin. Pract. 105 (2014), 141–150.
104. Evans, W.J., Paolisso, G., Abbatecola, A.M., Corsonello, A., Bustacchini, S., Strollo, F., Lattanzio, F., Frailty and muscle metabolism dysregulation in the elderly. Biogerontology 11 (2010), 527–536.
105. Exley, M.A., Hand, L., O'Shea, D., Lynch, L., Interplay between the immune system and adipose tissue in obesity. J. Endocrinol. 223 (2014), R41–R48.
106. Fabbri, E., Zoli, M., Gonzalez-Freire, M., Salive, M.E., Studenski, S.A., Ferrucci, L., Aging and multimorbidity: new tasks, priorities, and frontiers for integrated gerontological and clinical research. J. Am. Med. Dir. Assoc. 16 (2015), 640–647.
107. + T-cell populations and insulin resistance in obese individuals. Gastroenterology 45 (2013), 366–374.
108. Famulla, S., Lamers, D., Hartwig, S., Passlack, W., Horrighs, A., Cramer, A., Lehr, S., Sell, H., Eckel, J., Farr, O.M., Gavrieli, A., Mantzoros, C.S., Leptin applications in 2015: what have we learned about leptin and obesity?. Curr. Opin. Endocrinol. Diabetes Obes. 22 (2015), 353–359.
109. Fan, J., Song, Y., Chen, Y., Hui, R., Zhang, W., Combined effect of obesity and cardio-metabolic abnormality on the risk of cardiovascular disease: a meta-analysis of prospective cohort studies. Int. J. Cardiol. 12 (2013), 4761–4768.
110. Farr, O.M., Gavrieli, A., Mantzoros, C.S., Leptin applications in 2015: what have we learned about leptin and obesity?. Curr. Opin. Endocrinol. Diabetes Obes. 22 (2015), 353–359.
111. Febbraio, M.A., Role of interleukins in obesity: implications for metabolic disease. Trends Endocrinol. Metab. 25 (2014), 312–319.
112. Ferrante, A.W. Jr., The immune cells in adipose tissue. Diabetes Obes. Metab.(Suppl. 3), 2013, 34–38.
113. Filleur, S., Nelius, T., de Riese, W., Kennedy, R.C., Characterization of PEDF: a multi-functional serpin family protein. J. Cell. Biochem. 106 (2009), 769–775.
114. Fisher, F.M., Maratos-Flier, E., Understanding the physiology of FGF21. Annu. Rev. Physiol. 78 (2016), 223–241.
115. Fisher, F.M., Chui, P.C., Nasser, I.A., Popov, Y., Cunniff, J.C., Lundasen, T., Kharitonenkov, A., Schuppan, D., Flier, J.S., Maratos-Flier, E., Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets. Gastroenterology 147 (2014), 1073–1083.
116. Fitzgibbons, T.P., Czech, M.P., Emerging evidence for beneficial macrophage functions in atherosclerosis and obesity-induced insulin resistance. J. Mol. Med. (Berl.) 94 (2016), 267–275.
117. Florez, H., Troen, B.R., Fat and inflamm-aging: a dual path to unfitness in elderly people?. J. Am. Geriatr. Soc. 56 (2008), 558–560.
118. Franceschi, C., Bonafè, M., Valensin, S., Olivieri, F., De Luca, M., Ottaviani, E., DeBenedictis, G., Inflamm-aging: an evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 908 (2000), 244–254.
119. Friedman, J., Leptin and the Regulation of Food Intake and Body Weight. J. Nutr. Sci. Vitaminol. (Tokyo), 2015, 61 Suppl: S202.
120. Fuster, G., Almendro, V., Fontes-Oliveira, C.C., Toledo, M., Costelli, P., Busquets, S., López-Soriano, F.J., Argilés, J.M., Interleukin-15 affects differentiation and apoptosis in adipocytes: implications in obesity. Lipids 46 (2011), 1033–1042.
121. Gaggini, M., Saponaro, C., Gastaldelli, A., Not all fats are created equal: adipose vs. ectopic fat: implication in cardiometabolic diseases. Horm. Mol. Biol. Clin. Investig. 22 (2015), 7–18.
122. Gan, A.M., Butoi, E.D., Manea, A., Simion, V., Stanm, D., Parvulescu, M.M., Calin, M., Manduteanu, I., Simionescu, M., Inflammatory effects of resistin on human smooth muscle cells: up-regulation of fractalkine and its receptor, CX3CR1 expression by TLR4 and Gi-protein pathways. Cell Tissue Res. 351 (2013), 161–174.
123. Gapin, L., Development of invariant natural killer T cells. Curr. Opin. Immunol. 39 (2016), 68–74.
124. Gattu, A.K., Swenson, E.S., Iwakiri, Y., Samuel, V.T., Troiano, N., Berry, R., Church, C.D., Rodeheffer, M.S., Carpenter, T.O., Chung, C., Determination of mesenchymal stem cell fate by pigment epithelium-derived factor (PEDF) results in increased adiposity and reduced bone mineral content. FASEB J. 27 (2013), 4384–4394.
125. Gencer, B., Auer, R., de Rekeneire, N., Butler, J., Kalogeropoulos, A., Bauer, D.C., Kritchevsky, S.B., Miljkovic, I., Vittinghoff, E., Harris, T., Rodondi, N., Association between resistin levels and cardiovascular disease events in older adults: the health, aging and body composition study. Atherosclerosis 245 (2016), 181–186.
126. Ghazarian, M., Luck, H., Revelo, X.S., Winer, S., Winer, D.A., Immunopathology of adipose tissue during metabolic syndrome. Turk. Patoloji. Derg. 31:Suppl. 1 (2015), 172–180.
127. Goisser, S., Kemmler, W., Porzel, S., Volkert, D., Sieber, C.C., Bollheimer, L.C., Freiberger, E., Sarcopenic obesity and complex interventions with nutrition and exercise in community-dwelling older persons-a narrative review. Clin. Interv. Aging 10 (2015), 1267–1282.
128. Gondim, O.S., de Camargo, V.T., Gutierrez, F.A., Martins, P.F., Passos, M.E., Momesso, C.M., Santos, V.C., Gorjão, R., Pithon-Curi, T.C., Cury-Boaventura, M.F., Benefits of regular exercise on inflammatory and cardiovascular risk markers in normal weight, overweight and obese adults. PLoS One, 10, 2015, e0140596.
129. Goodpaster, B.H., He, J., Watkins, S., Kelley, D.E., Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J. Clin. Endocrinol. Metab. 86 (2001), 5755–5761.
130. Gordon, S., Taylor, P.R., Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5 (2015), 953–964.
131. Grant, R.W., Dixit, V.D., Adipose tissue as an immunological organ. Obesity (Silver Spring) 23 (2015), 512–518.
132. Grgurevic, L., Christensen, G.L., Schulz, T.J., Vukicevic, S., Bone morphogenetic proteins in inflammation: glucose homeostasis and adipose tissue energy metabolism. Cytokine Growth Factor Rev. 27 (2016), 105–118.
133. Hafizi Abu Bakar, M., Kian Kai, C., Wan Hassan, W.N., Sarmidi, M.R., Yaakob, H., Zaman Hur, i., Mitochondrial dysfunction as a central event for mechanisms underlying insulin resistance: the roles of long chain fatty acids. Diabetes Metab. Res. Rev. 31 (2015), 453–475.
134. + T regulatory cells and ameliorates adipose tissue inflammation and insulin resistance. J. Immunol. 194 (2015), 4777–4783.
135. Hansen, J.S., Pedersen, B.K., Xu, G., Lehmann, R., Weigert, C., Plomgaard, P., Exercise-induced secretion of FGF21 and follistatin are blocked by pancreatic clamp and impaired in type 2 diabetes. J. Clin. Endocrinol. Metab. 101 (2016), 2816–2825.
136. Harford, K.A., Reynolds, C.M., McGillicuddy, F.C., Roche, H.M., Fats, inflammation and insulin resistance: insights to the role of macrophage and T-cell accumulation in adipose tissue. Proc. Nutr. Soc. 70 (2011), 408–417.
137. Harris, L.A., Skinner, J.R., Shew, T.M., Pietka, T.A., Abumrad, N.A., Wolins, N.E., Perilipin 5-driven lipid droplet accumulation in skeletal muscle stimulates the expression of fibroblast growth factor 21. Diabetes 64 (2015), 2757–2768.
138. Hepple, R.T., Impact of aging on mitochondrial function in cardiac and skeletal muscle. Free Radic. Biol. Med.(March (23)), 2016.
139. Herová, M., Schmid, M., Gemperle, C., Hersberger, M., ChemR23, the receptor for chemerin and resolvin E1, is expressed and functional on M1 but not on M2 macrophages. J. Immunol. 194 (2015), 2330–2337.
140. Herranz, N., Gallage, S., Gil, J., TORn about SASP regulation. ABBV Cell Cycle 14 (2015), 3771–3772.
141. Ho-Pham, L.T., Nguyen, U.D., Nguyen, T.V., Association between lean mass, fat mass, and bone mineral density: a meta-analysis. J. Clin. Endocrinol. Metab. 99 (2014), 30–38.
142. Hojman, P., Pedersen, M., Nielsen, A.R., Krogh-Madsen, R., Yfanti, C., Akerstrom, T., Nielsen, S., Pedersen, B.K., Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia. Diabetes 58 (2009), 2797–2801.
143. Holland, W.L., Bikman, B.T., Wang, L.P., Yuguang, G., Sargent, K.M., Bulchand, S., Knotts, T.A., Shui, G., Clegg, D.J., Wenk, M.R., Pagliassotti, M.J., Scherer, P.E., Summers, S.A., Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J. Clin. Invest. 121 (2011), 1858–1870.
144. Hotamisligil, G.S., The role of TNF alpha and TNF receptors in obesity and insulin resistance. J. Intern. Med. 245 (1999), 621–625.
145. Hruschka, D.J., Hadley, C., How much do universal anthropometric standards bias the global monitoring of obesity and undernutrition?. Obes. Rev.(July (7)), 2016.
146. Huh, J.Y., Dincer, F., Mesfum, E., Mantzoros, C.S., Irisin stimulates muscle growth-related genes and regulates adipocyte differentiation and metabolism in humans. Int. J. Obes. (Lond.) 38 (2014), 1538–1544.
147. Huh, J.Y., Park, Y.J., Ham, M., Kim, J.B., Crosstalk between adipocytes and immune cells in adipose tissue inflammation and metabolic dysregulation in obesity. Mol. Cells 37 (2014), 365–371.
148. Hui, E., Yeung, C.Y., Lee, P.C., Woo, Y.C., Fong, C.H., Chow, W.S., Xu, A., Lam, K.S., Elevated circulating pigment epithelium-derived factor predicts the progression of diabetic nephropathy in patients with type 2 diabetes. J. Clin. Endocrinol. Metab. 99 (2014), E2169–2177.
149. Ilich, J.Z., Kelly, O.J., Inglis, J.E., Panton, L.B., Duque, G., Ormsbee, M.J., Interrelationship among muscle, fat, and bone: connecting the dots on cellular hormonal, and whole body levels. Ageing Res. Rev. 15 (2014), 51–60.
150. Ilich, J.Z., Inglis, J.E., Kelly, O.J., McGee, D.L., Osteosarcopenic obesity is associated with reduced handgrip strength, walking abilities, and balance in postmenopausal women. Osteoporos. Int. 26 (2015), 2587–2595.
151. Indulekha, K., Surendar, J., Anjana, R.M., Geetha, L., Gokulakrishnan, K., Pradeepa, R., Mohan, V., Metabolic obesity, adipocytokines, and inflammatory markers in Asian Indians-CURES-124. Diabetes Technol. Ther. 17 (2015), 134–141.
152. Ip, B., Cilfone, N.A., Belkina, A.C., DeFuria, J., Jagannathan-Bogdan, M., Zhu, M., Kuchibhatla, R., McDonnell, M.E., Xiao, Q., Kepler, T.B., Apovian, C.M., Lauffenburger, D.A., Nikolajczyk, B.S., Th17 cytokines differentiate obesity from obesity-associated type 2 diabetes and promote TNFα production. Obesity (Silver Spring) 24 (2016), 102–112.
153. Jacobi, S.K., Gabler, N.K., Ajuwon, K.M., Davis, J.E., Spurlock, M.E., Adipocytes, myofibers, and cytokine biology: new horizons in the regulation of growth and body composition. J. Anim. Sci. 84:Suppl (2006), E140–E149.
154. Javadov, S., Jang, S., Rodriguez-Reyes, N., Rodriguez-Zayas, A.E., Soto Hernandez, J., Krainz, T., Wipf, P., Frontera, W., Mitochondria-targeted antioxidant preserves contractile properties and mitochondrial function of skeletal muscle in aged rats. Oncotarget 6 (2015), 39469–39481.
155. Jenkins, A.J., Fu, D., Azar, M., Stoner, J.A., Kaufman, D.G., Zhang, S., Klein, R.L., Lopes-Virella, M.F., Ma, J.X., Lyons, T.J., Clinical correlates of serum pigment epithelium-derived factor in type 2 diabetes patients. J. Diabetes Complications 28 (2014), 353–359.
156. Jeon, J.Y., Choi, S.E., Ha, E.S., Kim, T.H., Jung, J.G., Han, S.J., Kim, H.J., Kim, D.J., Kang, Y., Lee, K.W., Association between insulin resistance and impairment of FGF21 signal transduction in skeletal muscles. Endocrine(January (12)), 2016.
157. Jiang, H., Westerterp, M., Wang, C., Zhu, Y., Ai, D., Macrophage mTORC1 disruption reduces inflammation and insulin resistance in obese mice. Diabetologia 57 (2014), 2393–2404.
158. Jin, P., Zhu, L., Zhang, J., Xie, S., Pan, D., Wen, H., Meng, W., Lin, L., Chen, D., A correlation study of the expression of resistin and glycometabolism in muscle tissue after traumatic brain injury in rats. Chin. J. Traumatol. 17 (2014), 125–129.
159. Jin, Y.J., Cao, P.J., Bian, W.H., Li, M.E., Zhou, R., Zhang, L.Y., Yang, M.Z., BDNF levels in adipose tissue and hypothalamus were reduced in mice with MSG-induced obesity. Nutr. Neurosci. 18 (2015), 376–382.
160. Johannsen, D.L., Conley, K.E., Bajpeyi, S., Punyanitya, M., Gallagher, D., Zhang, Z., Covington, J., Smith, S.R., Ravussin, E., Ectopic lipid accumulation and reduced glucose tolerance in elderly adults are accompanied by altered skeletal muscle mitochondrial activity. J. Clin. Endocrinol. Metab. 97 (2012), 242–250.
161. Johnson, A.M., Olefsky, J.M., The origins and drivers of insulin resistance. Cell 152 (2013), 673–684.
162. Kaeberlein, M., Rabinovitch, P.S., Martin, G.M., Healthy aging: the ultimate preventative medicine. Science 350 (2015), 1191–1193.
163. Kahles, F., Findeisen, H.M., Bruemmer, D., Osteopontin A novel regulator at the cross roads of inflammation, obesity and diabetes. Mol. Metab. 3 (2014), 384–393.
164. Kalinkovich, A., Livshits, G., Sarcopenia – the search for emerging biomarkers. Ageing Res. Rev. 22 (2015), 58–71.
165. Kang, Q., Song, W.X., Luo, Q., Tang, N., Luo, J., Luo, X., Chen, J., Bi, Y., He, B.C., Park, J.K., Jiang, W., Tang, Y., Huang, J., Su, Y., Zhu, G.H., He, Y., Yin, H., Hu, Z., Wang, Y., Chen, L., Zuo, G.W., Pan, X., Shen, J., Vokes, T., Reid, R.R., Haydon, R.C., Luu, H.H., He, T.C., A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cells Dev. 18 (2009), 545–559.
166. Kang, H.S., Liao, G., DeGraff, L.M., Gerrish, K., Bortner, C.D., Garantziotis, S., Jetten, A.M., CD44 plays a critical role in regulating diet-induced adipose inflammation, hepatic steatosis, and insulin resistance. PLoS One, 8, 2013, e58417.
167. Kase, E.T., Feng, Y.Z., Badin, P.M., Bakke, S.S., Lauren s, C., Coue, M., Langin, D., Gaster, M., Thoresen, G.H., Rustan, A.C., Moro, C., Primary defects in lipolysis and insulin action in skeletal muscle cells from type 2 diabetic individuals. Biochim. Biophys. Acta 1851 (2015), 1194–1201.
168. Keller-Peck, C.R., Feng, G., Sanes, J.R., Yan, Q., Lichtman, J.W., Snider, W.D., Glial cell line-derived neurotrophic factor administration in postnatal life results in motor unit enlargement and continuous synaptic remodeling at the neuromuscular junction. J. Neurosci. 21 (2001), 6136–6146.
169. Kelley, D.E., Goodpaster, B.H., Stewing in not-so-good juices: interactions of skeletal muscle with adipose secretions. Diabetes 64 (2015), 3055–3057.
170. Kerschensteiner, M., Gallmeier, E., Behrens, L., Leal, V.V., Misgeld, T., Klinkert, W.E., Kolbeck, R., Hoppe, E., Oropeza-Wekerle, R.L., Bartke, I., Stadelmann, C., Lassmann, H., Wekerle, H., Hohlfeld, R., Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?. J. Exp. Med. 189 (1999), 865–870.
171. Kiefer, F.W., Zeyda, M., Todoric, J., Huber, J., Geyeregger, R., Weichhart, T., Aszmann, O., Ludvik, B., Silberhumer, G.R., Prager, G., Stulnig, T.M., Osteopontin expression in human and murine obesity: extensive local up-regulation in adipose tissue but minimal systemic alterations. Endocrinology 149 (2008), 1350–1357.
172. Kiefer, F.W., Zeyda, M., Gollinger, K., Pfau, B., Neuhofer, A., Weichhart, T., Säemann, M.D., Geyeregger, R., Schlederer, M., Kenner, L., Stulnig, T.M., Neutralization of osteopontin inhibits obesity-induced inflammation and insulin resistance. Diabetes 59 (2010), 935–946.
173. Kiens, B., Alsted, T.J., Jeppesen, J., Factors regulating fat oxidation in human skeletal muscle. Obes. Rev. 12 (2011), 852–858.
174. Kim, T.N., Park, M.S., Ryu, J.Y., Choi, H.Y., Hong, H.C., Yoo, H.J., Kang, H.J., Song, W., Park, S.W., Baik, S.H., Newman, A.B., Choi, K.M., Impact of visceral fat on skeletal muscle mass and vice versa in a prospective cohort study: the Korean Sarcopenic Obesity Study (KSOS). PLoS One, 9, 2014, e115407.
175. Kim, Y.S., Jeon, J.Y., Nam, M., Effect of lifestyle modification on serum chemerin concentration and its association with insulin sensitivity in overweight and obese adults with type 2 diabetes. Clin. Endocrinol. (Oxf.) 80 (2014), 825–833.
176. Kintscher, U., Hartge, M., Hess, K., Foryst-Ludwig, A., Clemenz, M., Wabitsch, M., Fischer-Posovszky, P., Barth, T.F., Dragun, D., Skurk, T., Hauner, H., Blüher, M., Unger, T., Wolf, A.M., Knippschild, U., Hombach, V., arx, M., T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler. Thromb. Vasc. Biol. 28 (2008), 1304–1310.
177. Kob, R., Bollheimer, L.C., Bertsch, T., Fellner, C., Djukic, M., Sieber, C.C., Fischer, B.E., Sarcopenic obesity: molecular clues to a better understanding of its pathogenesis?. Biogerontology 16 (2015), 15–29.
178. Kohara, K., Sarcopenic obesity in aging population: current status and future directions for research. Endocrine 45 (2014), 15–25.
179. Kohlgruber, A., Lynch, L., Adipose tissue inflammation in the pathogenesis of type 2 diabetes. Curr. Diab. Rep., 15, 2015, 92.
180. Konopka, A.R., Sreekumaran, N.K., Mitochondrial and skeletal muscle health with advancing age. Mol. Cell Endocrinol. 379 (2013), 19–29.
181. Kopelman, P.G., Obesity as a medical problem. Nature 404 (2000), 635–643.
182. Korostishevsky, M., Steves, C.J., Malkin, I., Spector, T., Williams, F.M., Livshits, G., Genomics and metabolomics of muscular mass in community-based sample of UK females. Eur. J. Hum. Genet. 24 (2016), 277–283.
183. Kraakman, M.J., Murphy, A.J., Jandeleit-Dahm, K., Kammoun, H.L., Macrophage polarization in obesity and type 2 diabetes: weighing down our understanding of macrophage function?. Front. Immunol., 5, 2014, 470.
184. Kramer, C.K., Zinman, B., Retnakaran, R., Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis. Ann. Intern. Med. 159 (2013), 758–769.
185. Kratz, M., Coats, B.R., Hisert, K.B., Hagman, D., Mutskov, V., Peris, E., Schoenfelt, K.Q., Kuzma, J.N., Larson, I., Billing, P.S., Landerholm, R.W., Crouthamel, M., Gozal, D., Hwang, S., Singh, P.K., Becker, L., Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages. Cell. Metab. 20 (2014), 614–625.
186. 1H NMR spectroscopy study. Diabetologia 42 (1999), 113–116.
187. Kuo, M.M., Kim, S., Tseng, C.Y., Jeon, Y.H., Choe, S., Lee, D.K., BMP-9 as a potent brown adipogenic inducer with anti-obesity capacity. Biomaterials 35 (2014), 3172–3179.
188. Kurdiova, T., Balaz, M., Vician, M., Maderova, D., Vlcek, M., Valkovic, L., Srbecky, M., Imrich, R., Kyselovicova, O., Belan, V., Jelok, I., Wolfrum, C., Klimes, I., Krssak, M., Zemkova, E., Gasperikova, D., Ukropec, J., Ukropcova, B., Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies. J. Physiol. 592 (2014), 1091–1107.
189. Kwon, H., Pessin, J.E., Adipokines mediate inflammation and insulin resistance. Front. Endocrinol. (Lausanne), 4, 2013, 71.
190. Lackey, D.E., Olefsky, J.M., Regulation of metabolism by the innate immune system. Nat. Rev. Endocrinol. 12 (2016), 15–28.
191. Lavie, C.J., Milani, R.V., Artham, S.M., Patel, D.A., Ventura, H.O., The obesity paradox, weight loss, and coronary disease. Am. J. Med. 122 (2009), 1106–1114.
192. LeBrasseur, N.K., Tchkonia, T., Kirkland, J.L., Cellular senescence and the biology of aging disease, and frailty. Nestle Nutr. Inst. Workshop Ser. 83 (2015), 11–18.
193. Leduc-Gaudet, J.P., Picard, M., St-Jean Pelletier, F., Sgarioto, N., Auger, M.J., Vallée, J., Robitaille, R., St-Pierre, D.H., Gouspillou, G.m, Mitochondrial morphology is altered in atrophied skeletal muscle of aged mice. Oncotarget 6 (2015), 17923–17937.
194. Lee, S.J., McPherron, A.C., Regulation of myostatin activity and muscle growth. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 9306–9311.
195. Lee, S., Lee, H.C., Kwon, Y.W., Lee, S.E., Cho, Y., Kim, J., Lee, S., Kim, J.Y., Lee, J., Yang, H.M., Mook-Jung, I., Nam, K.Y., Chung, J., Lazar, M.A., Kim, H.S., Adenylyl cyclase-associated protein 1 is a receptor for human resistin and mediates inflammatory actions of human monocytes. Cell Metab. 19 (2014), 484–497.
196. Lee, J., Hong, Y.P., Shin, H.J., Lee, W., Associations of sarcopenia and sarcopenic obesity with metabolic syndrome considering both muscle mass and muscle strength. J. Prev. Med. Public Health 49 (2016), 35–44.
197. Lehr, S., Hartwig, S., Sell, H., Adipokines: a treasure trove for the discovery of biomarkers for metabolic disorders. Proteomics Clin. Appl. 6 (2012), 91–101.
198. Lehrke, M., Reilly, M.P., Millington, S.C., Iqbal, N., Rader, D.J., Lazar, M.A., An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med., 1, 2004, e45.
199. Lenk, K., Schuler, G., Adams, V., Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. J. Cachexia Sarcopenia Muscle 1 (2010), 9–21.
200. Li, F., Li, Y., Tang, Y., Lin, B., Kong, X., Oladele, O.A., Yin, Y., Protective effect of myokine IL-15 against H2O2-mediated oxidative stress in skeletal muscle cells. Mol. Biol. Rep. 41 (2014), 7715–7722.
201. Li, H.X., Chen, K.L., Wang, H.Y., Tang, C.B., Xu, X.L., Zhou, G.H., Chemerin inhibition of myogenesis and induction of adipogenesis in C2C12 myoblasts. Mol. Cell. Endocrinol. 414 (2015), 216–223.
202. Limongi, F., The CXCR3 chemokines in inflammatory myopathies. Clin. Ther. 166 (2015), e56–61.
203. Lin, Z., Pan, X., Wu, F., Ye, D., Zhang, Y., Wang, Y., Jin, L., Lian, Q., Huang, Y., Ding, H., Triggle, C., Wang, K., Li, X., Xu, A., Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice. Circulation 131 (2015), 1861–1871.
204. Liu, H.H., Lim, J.J., Aging and dyslipidemia: a review of potential mechanisms. Ageing Res. Rev. 19 (2015), 43–52.
205. Liu, K., Zhao, E., Ilyas, G., Lalazar, G., Lin, Y., Haseeb, M., Tanaka, K.E., Czaja, M.J., Impaired macrophage autophagy increases the immune response in obese mice by promoting proinflammatory macrophage polarization. Autophagy 11 (2015), 271–284.
206. Liu, L.F., Kodama, K., Wei, K., Tolentino, L.L., Choi, O., Engleman, E.G., Butte, A.J., McLaughlin, T., The receptor CD44 is associated with systemic insulin resistance and proinflammatory macrophages in human adipose tissue. Diabetologia 58 (2015), 1579–1586.
207. Livshits, G., Kato, B.S., Wilson, S.G., Spector, T.D., Linkage of genes to total lean body mass in normal women. J. Clin. Endocrinol. Metab. 92 (2007), 3171–3176.
208. Lloyd, J.W., Zerfass, K.M., Heckstall, E.M., Evans, K.A., Diet-induced increases in chemerin are attenuated by exercise and mediate the effect of diet on insulin and HOMA-IR. Ther. Adv. Endocrinol. Metab. 6 (2015), 189–198.
209. Loftus, R.M., Finlay, D.K., Immunometabolism: cellular metabolism turns immune regulator. J. Biol. Chem. 291 (2016), 1–10.
210. Lopez-Miranda, J., Perez-Martinez, P., It is time to define metabolically obese but normal-weight (MONW) individuals. Clin. Endocrinol. (Oxf.) 79 (2013), 314–315.
211. Loro, E., Seifert, E.L., Moffat, C., Romero, F., Mishra, M.K., Sun, Z., Krajacic, P., Anokye-Danso, F., Summer, R.S., Ahima, R.S., Khurana, T.S., IL-15Rα is a determinant of muscle fuel utilization, and its loss protects against obesity. Am. J. Physiol. Regul. Integr. Comp. Physiol. 309 (2015), R835–844.
212. Louche, K., Badin, P.M., Montastier, E., Laurens, C., Bourlier, V., de Glisezinski, I., Thalamas, C., Viguerie, N., Langin, D., Moro, C., Endurance exercise training up-regulates lipolytic proteins and reduces triglyceride content in skeletal muscle of obese subjects. J. Clin. Endocrinol. Metab. 98 (2013), 4863–4871.
213. Luangsay, S., Wittamer, V., Bondue, B., De Henau, O., Rouger, L., Brait, M., Franssen, J.D., de Nadai, P., Huaux, F., Parmentier, M., Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model. J. Immunol. 183 (2009), 6489–6499.
214. Lumeng, C.N., Deyoung, S.M., Saltiel, A.R., Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins. Am. J. Physiol. Endocrinol. Metab. 292 (2007), E166–174.
215. Lynch, L., Nowak, M., Varghese, B., Clark, J., Hogan, A.E., Toxavidis, V., Balk, S.P., O'Shea, D., O'Farrelly, C., Exley, M.A., Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. Immunity 37 (2012), 574–587.
216. Müller, M.J., Bosy-Westphal, A., Heller, M., ‘Functional’ body composition: differentiating between benign and non-benign obesity. F1000 Biol. Rep., 1, 2009, 75.
217. Müller, M.J., Braun, W., Enderle, J., Bosy-Westphal, A., Beyond BMI: conceptual issues related to overweight and obese patients. Obes. Facts 9 (2016), 193–205.
218. MacPherson, R.E., Peters, S.J., Piecing together the puzzle of perilipin proteins and skeletal muscle lipolysis. Appl. Physiol. Nutr. Metab. 40 (2015), 641–651.
219. MacPherson, R.E., Ramos, S.V., Wandenboom, R., Roy, B.D., Peters, S.J., Skeletal muscle PLIN proteins, ATGL and CGI-58: interactions at rest and following stimulated contraction. Am. J. Physiol. Regul. Integr. Comp. Physiol. 304 (2013), R644–R650.
220. Macaulay, R., Akbar, A.N., Henson, S.M., The role of the T cell in age-related inflammation. Age (Dordr) 35 (2013), 563–572.
221. Magalhaes, I., Kiaf, B., Lehuen, A., iNKT and MAIT cell alterations in diabetes. Front. Immunol., 6, 2015, 341.
222. Magalhaes, I., Pingris, K., Poitou, C., Bessoles, S., Venteclef, N., Kiaf, B., Beaudoin, L., Da Silva, J., Allatif, O., Rossjohn, J., Kjer-Nielsen, L., McCluskey, J., Ledoux, S., Genser, L., Torcivia, A., Soudais, C., Lantz, O., Boitard, C., Aron-Wisnewsky, J., Larger, E., Clément, K., Lehuen, A., Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients. J. Clin. Invest. 125 (2015), 1752–1762.
223. Maioli, T.U., Gonçalves, J.L., Miranda, M.C., Martins, V.D., Horta, L.S., Moreira, T.G., Godard, A.L., Santiago, A.F., Faria, A.M., High sugar and butter (HSB) diet induces obesity and metabolic syndrome with decrease in regulatory T cells in adipose tissue of mice. Inflamm. Res. 65 (2016), 169–178.
224. Makki, K., Froguel, P., Wolowczuk, I., Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm., 22, 2013, 139239.
225. Manfredsson, F.P., Tumer, N., Erdos, B., Landa, T., Broxson, C.S., Sullivan, L.F., Rising, A.C., Foust, K.D., Zhang, Y., Muzyczka, N., Gorbatyuk, O.S., Scarpace, P.J., Mandel, R.J., Nigrostriatal rAAV-mediated GDNF overexpression induces robust weight loss in a rat model of age-related obesity. Mol. Ther. 17 (2009), 980–991.
226. Mariani, F., Roncucci, L., Chemerin/chemR23 axis in inflammation onset and resolution. Inflamm. Res. 64 (2015), 85–95.
227. Marosi, K., Mattson, M.P., BDNF mediates adaptive brain and body responses to energetic challenges. Trends Endocrinol. Metab. 25 (2014), 89–98.
228. Martin, C.J., Peters, K.N., Behar, S.M., Macrophages clean up: efferocytosis and microbial control. Curr. Opin. Microbiol. 17 (2014), 17–23.
229. Marzetti, E., Calvani, R., Cesari, M., Buford, T.W., Lorenzi, M., Behnke, B.J., Leeuwenburgh, C., Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials. Int. J. Biochem. Cell Biol. 45 (2013), 2288–22301.
230. Mason, R.R., Mokhtar, R., Matzaris, M., Selathurai, A., Kowalski, G.M., Mokbel, N., Meikle, P.J., Bruce, C.R., Watt, M.J., PLIN5 deletion remodels intracellular lipid composition and causes insulin resistance in muscle. Mol. Metab. 3 (2014), 652–663.
231. Mathis, D., Shoelson, S.E., Immunometabolism: an emerging frontier. Nat. Rev. Immunol., 11, 2011, 81.
232. Mattern, A., Zellmann, T., Beck-Sickinger, A.G., Processing, signaling, and physiological function of chemerin. IUBMB Life 66 (2014), 19–26.
233. Maynard, S., Fang, E.F., Scheibye-Knudsen, M., Croteau, D.L., Bohr, V.A., DNA damage, DNA, repair, aging, and neurodegeneration. Cold Spring Harb. Perspect. Med., 5, 2015, 10.
234. McGregor, R.A., Cameron-Smith, D., Poppitt, S.D., It is not just muscle mass: a review of muscle quality, composition and metabolism during ageing as determinants of muscle function and mobility in later life. Longev. Healthspan, 3, 2014, 9.
235. McLaughlin, T., Liu, L.F., Lamendola, C., Shen, L., Morton, J., Rivas, H., Winer, D., Tolentino, L., Choi, O., Zhang, H., Hui Yen Chng, M., Engleman, E., T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans. Arterioscler. Thromb. Vasc. Biol. 34 (2014), 2637–2643.
236. McPherron, A.C., The ups and downs of exercise and insulin sensitivity: a role for the myokine myostatin in glucose metabolism?. Acta Physiol. (Oxf.) 217 (2016), 6–10.
237. McTernan, C.L., McTernan, P.G., Harte, A.L., Levick, P.L., Barnett, A.H., Kumar, S., Resistin, central obesity, and type 2 diabetes. Lancet 359 (2002), 46–47.
238. Mehta, P., Nuotio-Antar, A.M., Smith, C.W., γδ T cells promote inflammation and insulin resistance during high fat diet-induced obesity in mice. J. Leukoc. Biol. 97 (2015), 121–134.
239. Meijer, K., de Vries, M., Al-Lahham, S., Bruinenberg, M., Weening, D., Dijkstra, M., Kloosterhuis, N., van der Leij, R.J., van der Want, H., Kroesen, B.J., Vonk, R., Rezaee, F., Human primary adipocytes exhibit immune cell function: adipocytes prime inflammation independent of macrophages. PLoS One, 6, 2011, e17154.
240. Michaud, M., Balardy, L., Moulis, G., Gaudin, C., Peyrot, C., Vellas, B., Cesari, M., Nourhashemi, F., Minihane, A.M., Vinoy, S., Russell, W.R., Baka, A., Roche, H.M., Tuohy, K.M., Teeling, J.L., Blaak, E.E., Fenech, M., Vauzour, D., McArdle, H.J., Kremer, B.H., Sterkman, L., Vafeiadou, K., Benedetti, M.M., Williams, C.M., Calder, P.C., Low-grade inflammation, diet composition and health: current research evidence and its translation. Br. J. Nutr. 114 (2015), 999–1012.
241. Minihane, A.M., Vinoy, S., Russell, W.R., Baka, A., Roche, H.M., Tuohy, K.M., Teeling, J.L., Blaak, E.E., Fenech, M., Vauzour, D., McArdle, H.J., Kremer, B.H., Sterkman, L., Vafeiadou, K., Benedetti, M.M., Williams, C.M., Calder, P.C., Low-grade inflammation, diet composition and health: current research evidence and its translation. Br. J. Nutr. 114 (2015), 999–1012.
242. Mitchell, W.K., Williams, J., Atherton, P., Larvin, M., Lund, J., Narici, M., Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review. Front. Physiol., 3, 2012, 260.
243. Miyatake, S., Bilan, P.J., Pillon, N.J., Klip, A., Contracting C2C12 myotubes release CCL2 in an NF-κB-dependent manner to induce monocyte chemoattraction. Am. J. Physiol. Endocrinol. Metab. 310 (2016), E160–170.
244. Molino, S., Dossena, M., Buonocore, D., Verri, M., Sarcopenic obesity: an appraisal of the current status of knowledge and management in elderly people. J. Nutr. Health Aging 20 (2016), 780–788.
245. Monteiro-Junior, R.S., Cevada, T., Oliveira, B.R., Lattari, E., Portugal, E.M., Carvalho, A., Deslandes, A.C., We need to move more: neurobiological hypotheses of physical exercise as a treatment for Parkinson's disease. Med. Hypotheses 85 (2015), 537–541.
246. Moreno-Navarrete, J.M., Ortega, F., Serrano, M., Guerra, E., Pardo, G., Tinahones, F., Ricart, W., Fernández-Real, J.M., Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J. Clin. Endocrinol. Metab. 98 (2013), E769–778.
247. + T cells in mice. Diabetes 62 (2013), 2762–2772.
248. Moyers, J.S., Shiyanova, T.L., Mehrbod, F., Dunbar, J.D., Noblitt, T.W., Otto, K.A., Reifel-Miller, A., Kharitonenkov, A., Molecular determinants of FGF-21 activity-synergy and cross-talk with PPARgamma signaling. J. Cell. Physiol. 210 (2007), 1–6.
249. Muoio, D.M., Revisiting the connection between intramyocellular lipids and insulin resistance: a long and winding road. Diabetologia 55 (2012), 2551–2554.
250. Mwangi, S.M., Nezami, B.G., Obukwelu, B., Anitha, M., Marri, S., Fu, P., Epperson, M.F., Le, N.A., Shanmugam, M., Sitaraman, S.V., Tseng, Y.H., Anania, F.A., Srinivasan, S., Glial, cell line-derived neurotrophic factor protects against high-fat diet-induced obesity. Am. J. Physiol. Gastrointest. Liver Physiol. 306 (2014), G515–525.
251. Naylor, C., Petri, W.A. Jr., Leptin regulation of immune responses. Trends Mol. Med. 22 (2016), 88–98.
252. Nguyen, Q.T., Parsadanian, A.S., Snider, W.D., Lichtman, J.W., Hyperinnervation of neuromuscular junctions caused by GDNF overexpression in muscle. Science 279 (1998), 1725–1729.
253. Nimmo, M.A., Leggate, M., Viana, J.L., King, J.A., The effect of physical activity on mediators of inflammation. Diabetes Obes. Metab.(Suppl. 3), 2013, 51–60.
254. Nishimura, S., Manabe, I., Nagasaki, M., Eto, K., Yamashita, H., Ohsugi, M., Otsu, M., Hara, K., Ueki, K., Sugiura, S., Yoshimura, K., Kadowaki, T., Nagai, R., CD8 effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 15 (2009), 914–920.
255. Nomiyama, T., Perez-Tilve, D., Ogawa, D., Gizard, F., Zhao, Y., Heywood, E.B., Jones, K.L., Kawamori, R., Cassis, L.A., Tschöp, M.H., Bruemmer, D., Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J. Clin. Invest. 117 (2007), 2877–2888.
256. Numakawa, T., Suzuki, S., Kumamaru, E., Adachi, N., Richards, M., Kunugi, H., BDNF function and intracellular signaling in neurons. Histol. Histopathol. 25 (2010), 237–258.
257. O'Connell, G.C., Pistilli, E.E., Interleukin-15 directly stimulates pro-oxidative gene expression in skeletal muscle in-vitro via a mechanism that requires interleukin-15 receptor alpha. Biochem. Biophys. Res. Commun. 458 (2015), 614–619.
258. O'Neill, S., O'Driscoll, L., Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes. Rev. 16 (2015), 1–12.
259. Odegaard, J.I., Chawla, A., Type 2 responses at the interface between immunity and fat metabolism. Curr. Opin. Immunol. 36 (2015), 67–72.
260. Odegaard, J.I., Ricardo-Gonzalez, R.R., Goforth, M.H., Morel, C.R., Subramanian, V., Mukundan, L., Red Eagle, A., Vats, D., Brombacher, F., Ferrante, A.W., Chawla, A., Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 447 (2007), 1116–1120.
261. Ogawa, Y., Kurosu, H., Yamamoto, M., Nandi, A., Rosenblatt, K.P., Goetz, R., Eliseenkova, A.V., Mohammadi, M., Kuro-o, M., BetaKlotho is required for metabolic activity of fibroblast growth factor 21. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 7432–7437.
262. Olefsky, J.M., Glassm, C.K., Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol. 72 (2010), 219–246.
263. Oreopoulos, A., Kalantar-Zadeh, K., Sharma, A.M., Fonarow, G.C., The obesity paradox in the elderly: potential mechanisms and clinical implications. Clin. Geriatr. Med. 25 (2009), 643–659.
264. Orlova, E.G., Shirshev, S.V., Role of leptin and ghrelin in induction of differentiation of IL-17-producing and T-regulatory cells. Bull. Exp. Biol. Med. 156 (2014), 819–822.
265. Ormsbee, M.J., Prado, C.M., Ilich, J.Z., Purcell, S., Siervo, M., Folsom, A., Panton, L., Osteosarcopenic obesity: the role of bone, muscle, and fat on health. J. Cachexia Sarcopenia Muscle 5 (2014), 183–192.
266. Osborn, O., Olefsky, J.M., The cellular and signaling networks linking the immune system and metabolism in disease. Nat. Med. 18 (2012), 363–374.
267. Ovadya, Y., Krizhanovsky, V., Senescent cells: sASPected drivers of age-related pathologies. Biogerontology 15 (2014), 627–642.
268. Pagel, C.N., Wasgewatte Wijesinghe, D.K., Taghavi Esfandouni, N., Mackie, E.J., Osteopontin, inflammation and myogenesis: influencing regeneration, fibrosis and size of skeletal muscle. J. Cell. Commun. Signal. 8 (2014), 95–103.
269. Pajenda, G., Hercher, D., Márton, G., Pajer, K., Feichtinger, G.A., Maléth, J., Redl, H., Nógrádi, A., Paliwal, P., Pishesha, N., Wijaya, D., Conboy, I.M., Age dependent increase in the levels of osteopontin inhibits skeletal muscle regeneration. Aging (Albany NY) 4 (2012), 553–566.
270. Pantsulaia, I., Livshits, G., Trofimov, S., Kobyliansky, E., Genetic and environmental determinants of circulating resistin level in a community-based sample. Eur. J. Endocrinol. 156 (2007), 129–135.
271. Papathanassoglou, E.D., Miltiadous, P., Karanikola, M.N., May BDNF Be implicated in the exercise-Mediated regulation of inflammation?: critical review and synthesis of evidence. Biol. Res. Nurs. 17 (2015), 521–539.
272. Pardo, M., Crujeiras, A.B., Amil, M., Aguera, Z., Jiménez-Murcia, S., Baños, R., Botella, C., de la Torre, R., Estivill, X., Fagundo, A.B., Fernández-Real, J.M., Fernández-García, J.C., Fruhbeck, G., Gómez-Ambrosi, J., Rodríguez, R., Tinahones, F.J., Fernández-Aranda, F., Casanueva, F.F., Association of irisin with fat mass, resting energy expenditure, and daily activity in conditions of extreme body mass index. Int. J. Endocrinol., 2014, 2014, 857270.
273. Park, H.K., Ahima, R.S., Resistin in rodents and humans. Diabetes Metab. J. 37 (2013), 404–414.
274. Patel, L., Buckels, A.C., Kinghorn, I.J., Murdock, P.R., Holbrook, J.D., Plumpton, C., Macphee, C.H., Smith, S.A., Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem. Biophys. Res. Commun. 300 (2003), 472–476.
275. Patsouris, D., Cao, J.J., Vial, G., Bravard, A., Lefai, E., Durand, A., Durand, C., Chauvin, M.A., Laugerette, F., Debard, C., Michalski, M.C., Laville, M., Vidal, H., Rieusset, J., Insulin resistance is associated with MCP1-mediated macrophage accumulation in skeletal muscle in mice and humans. PLoS One, 9, 2014, e110653.
276. Pedersen, B.K., Muscle as a secretory organ. Compr. Physiol. 3 (2013), 1337–1362.
277. Pellegrinelli, V., Rouault, C., Rodriguez-Cuenca, S., Albert, V., Edom-Vovard, F., Vidal-Puig, A., Clément, K., Butler-Browne, G.S., Lacasa, D., Human adipocytes induce inflammation and atrophy in muscle cells during obesity. Diabetes 64 (2015), 3121–3134.
278. Pereira, S.S., Alvarez-Leite, J.I., Low-grade inflammation, obesity, and diabetes. Curr. Obes. Rep. 3 (2014), 422–431.
279. Peters, S.J., Samjoo, I.A., Devries, M.C., Stevic, I., Robertshaw, H.A., Tarnopolsky, M.A., Perilipin family (PLIN) proteins in human skeletal muscle: the effect of sex, obesity, and endurance training. Appl. Physiol. Nutr. Metab. 37 (2012), 724–735.
280. Pham, C.T., Neutrophil serine proteases: specific regulators of inflammation. Nat. Rev. Immunol. 6 (2006), 541–550.
281. Phillips, C.M., Perry, I.J., Does inflammation determine metabolic health status in obese and nonobese adults?. J. Clin. Endocrinol. Metab. 98 (2013), E1610–E1619.
282. Pol, A., Gross, S.P., Parton, R.G., Review: biogenesis of the multifunctional lipid droplet: lipids, proteins, and sites. J. Cell. Biol. 204 (2014), 635–646.
283. Prado, C.M., Cushen, S.J., Orsso, C.E., Ryan, A.M., Sarcopenia and cachexia in the era of obesity: clinical and nutritional impact. Proc. Nutr. Soc. 75 (2016), 188–198.
284. Procaccini, C., Jirillo, E., Matarese, G., Leptin as an immunomodulator. Mol. Aspects Med. 33 (2013), 35–45.
285. Qiu, Y., Nguyen, K.D., Odegaard, J.I., Cui, X., Tian, X., Locksley, R.M., Palmiter, R.D., Chawla, A., Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell 157 (2014), 1292–1308.
286. Quinn, L.S., Anderson, B.G., Conner, J.D., Wolden-Hanson, T., IL-15 overexpression promotes endurance, oxidative energy metabolism, and muscle PPARδ, SIRT1, PGC-1α, and PGC-1β expression in male mice. Endocrinology 154 (2013), 232–245.
287. Ramos, S.V., MacPherson, R.E., Turnbull, P.C., Bott, K.N., LeBlanc, P., Ward, W.E., Peters, S.J., Higher, M., PLIN5 but not PLIN3 content in isolated skeletal muscle mitochondria following acute in vivo contraction in rat hindlimb. Physiol. Rep., 2, 2014, e12154.
288. Ramos-Ramírez, P., Malmhäll, C., Johansson, K., Lötvall, J., Bossios, A., Weight gain alters adiponectin receptor 1 expression on adipose tissue-resident helios+regulatory T cells. Scand. J. Immunol. 83 (2016), 244–254.
289. Raschke, S., Eckel, J., Adipo-myokines: two sides of the same coin–mediators of inflammation and mediators of exercise. Mediators Inflamm., 2013, 2013, 320724.
290. Ren, J., Anversa, P., The insulin-like growth factor I system: physiological and pathophysiological implication in cardiovascular diseases associated with metabolic syndrome. Biochem. Pharmacol. 93 (2015), 409–417.
291. Reis, B.S., Lee, K., Fanok, M.H., Mascaraque, C., Amoury, M., Cohn, L.B., Rogoz, A., Dallner, O.S., Moraes-Vieira, P.M., Domingos, A.I., Mucida, D., Leptin receptor signaling in T cells is required for Th17 differentiation. J. Immunol. 194 (2015), 5253–5260.
292. Rey-López, J.P., de Rezende, L.F., Pastor-Valero, M., Tess, B.H., The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the definitions used. Obes. Rev. 15 (2014), 781–790.
293. Rinnov, A., Yfanti, C., Nielsen, S., Akerstrom, T.C., Peijs, L., Zankari, A., Fischer, C.P., Pedersen, B.K., Endurance training enhances skeletal muscle interleukin-15 in human male subjects. Endocrine 45 (2014), 271–278.
294. Ritter, O., Jelenik, T., Roden, M., Lipid-mediated muscle insulin resistance: different fat, different pathways?. J. Mol. Med. (Berl.) 93 (2015), 831–843.
295. Rivas, D.A., Mcdonald, D.J., Rice, N.P., Haran, P.H., Dolnikowski, G.G., Fielding, R.A., Diminished anabolic signaling response to insulin induced by intramuscular lipid accumulation is associated with inflammation in aging but not obesity. Am. J. Physiol. Regul. Integr. Comp. Physiol.(January (13)), 2016.
296. Robenek, H., Robenek, M.J., Buers, I., Lorkowski, S., Hofnagel, O., Troyer, D., Severs, N.J., Lipid droplets gain PAT family proteins by interaction with specialized plasma membrane domains. J. Biol. Chem. 280 (2005), 26330–26338.
297. Roberson, L.L., Aneni, E.C., Maziak, W., Agatston, A., Feldman, T., Rouseff, M., Tran, T., Blaha, M.J., Santos, R.D., Sposito, A., Al-Mallah, M.H., Blankstein, R., Budoff, M.J., Nasir, K., Beyond BMI: The Metabolically healthy obese phenotype and its association with clinical/subclinical cardiovascular disease and all-cause mortality − a systematic review. BMC Public Health, 14, 2014, 14.
298. Roca-Rivada, A., Castelao, C., Senin, L.L., Landrove, M.O., Baltar, J., Belén Crujeiras, A., Seoane, L.M., Casanueva, F.F., Pardo, M., FNDC5/irisin is not only a myokine but also an adipokine. PLoS One, 8, 2013, e60563.
299. Rocher, C., Singla, D.K., SMAD-PI3K-Akt-mTOR pathway mediates BMP-7 polarization of monocytes into M2 macrophages. PLoS One, 8, 2013, e84009.
300. Rodríguez, A., Ezquerro, S., Méndez-Giménez, L., Becerril, S., Frühbeck, G., Revisiting the adipocyte: a model for integration of cytokine signaling in the regulation of energy metabolism. Am. J. Physiol. Endocrinol. Metab. 309 (2015), E691–E714.
301. Roh, S.G., Song, S.H., Choi, K.C., Katoh, K., Wittamer, V., Parmentier, M., Sasaki, S., Chemerin-a new adipokine that modulates adipogenesis via its own receptor. Biochem. Biophys. Res. Commun. 362 (2007), 1013–1018.
302. Rolland, Y., Lauwers-Cances, V., Cristini, C., van Kan, G.A., Janssen, I., Morley, J.E., Vellas, B., Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l'OSteoporose) Study. Am. J. Clin. Nutr. 89 (2009), 1895–1900.
303. Romacho, T., Glosse, P., Richter, I., Elsen, M., Schoemaker, M.H., van Tol, E.A., Eckel, J., Nutritional ingredients modulate adipokine secretion and inflammation in human primary adipocytes. Nutrients 7 (2015), 865–886.
304. Romanello, V., Sandri, M., Mitochondrial quality control and muscle mass maintenance. Front. Physiol., 6, 2016, 422.
305. Rosenberg, I.H., Summary comments: epidemiological and methodological problems in determining nutritional status of older persons. Am. J. Clin. Nutr. 50 (1989), 1231–1233.
306. Roubenoff, R., Sarcopenic obesity: does muscle loss cause fat gain?: Lessons from rheumatoid arthritis and osteoarthritis. Ann. N.Y. Acad. Sci. 904 (2000), 553–557.
307. Rourke, J.L., Dransem, H.J., Sinal, C.J., Towards an integrative approach to understanding the role of chemerin in human health and disease. Obes. Rev. 14 (2013), 245–262.
308. Ruderman, N.B., Schneider, S.H., Berchtold, P., The “metabolically-obese,” normal-weight individual. Am. J. Clin. Nutr. 34 (1981), 1617–1621.
309. Rutkowski, J.M., Stern, J.H., Scherer, P.E., The cell biology of fat expansion. J. Cell. Biol. 208 (2015), 501–512.
310. Sakuma, K., Yamaguchi, A., Sarcopenic obesity and endocrinal adaptation with age. Int. J. Endocrinol., 2013, 204164.
311. Sakuma, K., Aoi, W., Yamaguchi, A., Current understanding of sarcopenia: possible candidates modulating muscle mass. Pflugers Arch. 467 (2015), 213–229.
312. Salama, R., Sadaie, M., Hoare, M., Narita, M., Cellular senescence and its effector programs. Genes Dev. 28 (2014), 99–114.
313. Salminen, A., Kauppinen, A., Kaarniranta, K., Emerging role of NF-κB signaling in the induction of senescence-associated secretory phenotype (SASP). Cell. Signal. 24 (2012), 835–845.
314. Samms, R.J., Cheng, C.C., Kharitonenkov, A., Gimeno, R.E., Adams, A.C., Overexpression of β-Klotho in adipose tissue sensitizes male mice to endogenous FGF21 and provides protection from diet-Induced obesity. Endocrinology 157 (2016), 1467–1480.
315. Samuel, V.T., Shulman, G.I., The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J. Clin. Invest. 126 (2016), 12–22.
316. Santilli, V., Bernetti, A., Mangone, M., Paoloni, M., Clinical definition of sarcopenia. Clin. Cases Miner. Bone Metab. 11 (2014), 177–180.
317. Sartori, R., Sandri, M., BMPs and the muscle-bone connection. Bone 80 (2015), 37–42.
318. Sartori, R., Gregorevic, P., Sandri, M., TGFβ and BMP signaling in skeletal muscle: potential significance for muscle-related disease. Trends Endocrinol. Metab. 25 (2014), 464–471.
319. Schafer, M.J., White, T.A., Evans, G., Tonne, J.M., Verzosa, G.C., Stout, M.B., Mazula, D.L., Palmer, A.K., Baker, D.J., Jensen, M.D., Torbenson, M.S., Miller, J.D., Ikeda, Y., Tchkonia, T., van Deursen, J.M., Kirkland, J.L., LeBrasseur, N.K., Exercise prevents diet-Induced cellular senescence in adipose tissue. Diabetes 65 (2016), 1606–1615.
320. Schelbert, K.B., Comorbidities of obesity. Prim. Care 2 (2009), 271–285.
321. Scherer, P.E., Williams, S., Fogliano, M., Baldini, G., Lodish, H.F., A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270 (1995), 26746–26749.
322. Schering, L., Hoene, M., Kanzleiter, T., Jähnert, M., Wimmers, K., Klaus, S., Eckel, J., Weigert, C., Schürmann, A., Maak, S., Jonas, W., Sell, H., Identification of novel putative adipomyokines by a cross-species annotation of secretomes and expression profiles. Arch. Physiol. Biochem. 121 (2015), 194–205.
323. Schipper, H.S., Prakken, B., Kalkhoven, E., Boes, M., Adipose tissue-resident immune cells: key players in immunometabolism. Trends Endocrinol. Metab. 23 (2012), 407–415.
324. Schrager, M.A., Metter, E.J., Simonsick, E., Ble, A., Bandinelli, S., Lauretani, F., Ferrucci, L., Sarcopenic obesity and inflammation in the InCHIANTI study. J. Appl. Physiol. 102 (2007), 919–925.
325. Schwarz, N.A., McKinley-Barnard, S.K., Spillane, M.B., Andre, T.L., Gann, J.J., Willoughby, D.S., Effect of resistance exercise intensity on the expression of PGC-1α isoforms and the anabolic and catabolic signaling mediators IGF-1 and myostatin, in human skeletal muscle. Appl. Physiol. Nutr. Metab. 41 (2016), 856–863.
326. Sciorati, C., Rigamonti, E., Manfredi, A.A., Rovere-Querini, P., Cell death, clearance and immunity in the skeletal muscle. Cell Death Differ.(February (12)), 2016.
327. Seijkens, T., Kusters, P., Chatzigeorgiou, A., Chavakis, T., Lutgens, E., Immune cell crosstalk in obesity: a key role for costimulation?. Diabetes 63 (2014), 3982–3991.
328. Sell, H., Divoux, A., Poitou, C., Basdevant, A., Bouillot, J.L., Bedossa, P., Tordjman, J., Eckel, J., Clément, K., Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. J. Clin. Endocrinol. Metabol. 95 (2010), 2892–2896.
329. Sell, H., Habich, C., Eckel, J., Adaptive immunity in obesity and insulin resistance. Nat. Rev. Endocrinol. 8 (2012), 709–716.
330. Sente, T., Van Berendoncks, A.M., Fransen, E., Vrints, C.J., Hoymans, V.Y., Tumor necrosis factor-α impairs adiponectin signalling, mitochondrial biogenesis and myogenesis in primary human myotubes cultures. Am. J. Physiol. Heart Circ. Physiol.(February (26)), 2016.
331. Shepherd, S.O., Cocks, M., Tipton, K.D., Ranasinghe, A.M., Barker, T.A., Burniston, J.G., Wagenmakers, A.J.M., Shaw, C.S., Sprint interval and traditional endurance training increase net intramuscular triglyceride breakdown and expression of perilipin 2 and 5. J. Physiol. 591 (2013), 657–675.
332. Sikora, E., Bielak-Zmijewska, A., Mosieniak, G., Cellular senescence in ageing, age-related disease and longevity. Curr. Vasc. Pharmacol. 12 (2014), 698–706.
333. Singhal, G., Fisher, F.M., Chee, M.J., Tan, T.G., El Ouaamari, A., Adams, A.C., Najarian, R., Kulkarni, R.N., Benoist, C., Flier, J.S., Maratos-Flier, E., Fibroblast growth factor 21 (FGF21) protects against high fat diet induced inflammation and islet hyperplasia in pancreas. PLoS One, 11, 2016, e0148252.
334. Singla, D.K., Singla, R., Wang, J., BMP-7 treatment increases M2 macrophage differentiation and reduces inflammation and plaque formation in apo E-/- mice. PLoS One, 11, 2016, e0147897.
335. Sjöblom, S., Suuronen, J., Rikkonen, T., Honkanen, R., Kröger, H., Sirola, J., Relationship between postmenopausal osteoporosis and the components of clinical sarcopenia. Maturitas 75 (2013), 175–180.
336. Smitka, K., Marešová, D., Adipose tissue as an endocrine organ: an update on pro-inflammatory and anti-inflammatory microenvironment. Prague Med. Rep. 116 (2015), 87–111.
337. Sousa-Victor, P., Muñoz-Cánoves, P., Regenerative decline of stem cells in sarcopenia. Mol. Aspects Med., 24, 2016.
338. Sriram, S., Subramanian, S., Sathiakumar, D., Venkatesh, R., Salerno, M.S., McFarlane, C.D., Kambadur, R., Sharma, M., Modulation of reactive oxygen species in skeletal muscle by myostatin is mediated through NF-κB. Aging Cell 10 (2011), 931–948.
339. Stefan, N., Kantartzis, K., Machann, J., Schick, F., Thamer, C., Rittig, K., Balletshofer, B., Machicao, F., Fritsche, A., Häring, H.U., Identification and characterization of metabolically benign obesity in humans. Arch. Intern. Med. 168 (2008), 1609–1616.
340. Stefanov, T., Blüher, M., Vekova, A., Bonova, I., Tzvetkov, S., Kurktschiev, D., Temelkova-Kurktschiev, T., Circulating chemerin decreases in response to a combined strength and endurance training. Endocrine 45 (2014), 382–391.
341. Stenholm, S., Harris, T.B., Rantanen, T., Visser, M., Kritchevsky, S.B., Ferrucci, L., Sarcopenic obesity: definition, cause and consequences. Curr. Opin. Clin. Nutr. Metab. Care 11 (2008), 693–700.
342. Stephenson, E.J., Smiles, W., Hawley, J.A., The relationship between exercise, nutrition and type 2 diabetes. Med. Sport Sci. 60 (2014), 1–10.
343. Steppan, C.M., Bailey, S.T., Bhat, S., Brown, E.J., Banerjee, R.R., Wright, C.M., Patel, H.R., Ahima, R.S., Lazar, M.A., The hormone resistin links obesity to diabetes. Nature 409 (2001), 212–307.
344. Stinkens, R., Goossens, G.H., Jocken, J.W., Blaak, E.E., Targeting fatty acid metabolism to improve glucose metabolism. Obes. Rev. 16 (2015), 715–757.
345. Subramanian, S., Turner, M.S., Ding, Y., Goodspeed, L., Wang, S., Buckner, J.H., O'Brien, K., Getz, G.S., Reardon, C.A., Chait, A., Increased levels of invariant natural killer T lymphocytes worsen metabolic abnormalities and atherosclerosis in obese mice. J. Lipid Res. 54 (2013), 2341–2813.
346. Sun, H., Liu, D., Hydrodynamic delivery of interleukin 15 gene promotes resistance to high fat diet-induced obesity, fatty liver and improves glucose homeostasis. Gene Ther. 22 (2015), 341–347.
347. Sun, H., Ma, Y., Gao, M., Liu, D., IL-15/sIL-15Rα gene transfer induces weight loss and improves glucose homeostasis in obese mice. Gene Ther.(January (16)), 2016.
348. Sunderland, K.L., Tryggestad, J.B., Wang, J.J., Teague, A.M., Pratt, L.V., Zhang, S.X., Thompson, D.M., Short, K.R., Pigment epithelium-derived factor (PEDF) varies with body composition and insulin resistance in healthy young people. J. Clin. Endocrinol. Metab. 97 (2012), E2114–2118.
349. Suzuki, Y., Hong, Y.H., Song, S.H., Ardiyanti, A., Kato, D., So, K.H., Katoh, K., Roh, S.G., The regulation of chemerin and CMKLR1 genes expression by TNF-α adiponectin, and chemerin analog in bovine differentiated adipocytes. Asian-Australas J. Anim. Sci. 25 (2012), 1316–1321.
350. Sztalryd, C., Kimmel, A.R., Perilipins: lipid droplet coat proteins adapted for tissue-specific energy storage and utilization and lipid cytoprotection. Biochimie 96 (2014), 96–101.
351. Tahara, N., Yamagishi, S., Tahara, A., Nitta, Y., Kodama, N., Mizoguchi, M., Mohar, D., Ishibashi, M., Hayabuchi, N., Imaizumi, T., Serum level of pigment epithelium-derived factor is a marker of atherosclerosis in humans. Atherosclerosis 219 (2011), 311–315.
352. Takahashi, M., Takahashi, Y., Takahashi, K., Zolotaryov, F.N., Hong, K.S., Kitazawa, R., Iida, K., Okimura, Y., Kaji, H., Kitazawa, S., Kasuga, M., Chihara, K., Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS Lett. 582 (2008), 573–578.
353. Talukdar, S., Ohda, Y., Bandyopadhyay, G., Li, D., Xu, J., McNelis, J., Lu, M., Li, P., Yan, Q., Zhu, Y., Ofrecio, J., Lin, M., Brenner, M.B., Olefsky, J.M., Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat. Med. 18 (2012), 1407–1412.
354. Tard, C., Rouxel, O., Lehuen, A., Regulatory role of natural killer T cells in diabetes. Biomed. J. 38 (2015), 484–495.
355. Tateya, S., Kim, F., Tamori, Y., Recent advances in obesity-induced inflammation and insulin resistance. Front. Endocrinol. (Lausanne), 4, 2013, 93.
356. Tchkonia, T., Morbeck, D.E., Von Zglinicki, T., Van Deursen, J., Lustgarten, J., Scrable, H., Khosla, S., Jensen, M.D., Kirkland, J.L., Fat tissue, aging, and cellular senescence. Aging Cell 9 (2010), 667–684.
357. Tchkonia, T., Thomou, T., Zhu, Y., Karagiannides, I., Pothoulakis, C., Jensen, M.D., Kirkland, J.L., Mechanisms and metabolic implications of regional differences among fat depots. Cell Metab. 17 (2013), 644–656.
358. Tilg, H., Moschen, A.R., Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 6 (2006), 772–783.
359. Torres, A., Makowski, L., Wellen, K.E., Metabolism fine-tunes macrophage activation. Elife, 5, 2016, e14354.
360. Townsend, K.L., Suzuki, R., Huang, T.L., Jing, E., Schulz, T.J., Lee, K., Taniguchi, C.M., Espinoza, D.O., McDougall, L.E., Zhang, H., He, T.C., Kokkotou, E., Tseng, Y.H., Bone morphogenetic protein 7 (BMP7) reverses obesity and regulates appetite through a central mTOR pathway. FASEB J. 26 (2012), 2187–2196.
361. Travers, R.L., Motta, A.C., Betts, J.A., Bouloumié, A., Thompson, D., The impact of adiposity on adipose tissue-resident lymphocyte activation in humans. Int. J. Obes. (Lond.) 39 (2015), 762–769.
362. Tsai, S., Clemente-Casares, X., Revelo, X.S., Winer, S., Winer, D.A., Are obesity-related insulin resistance and type 2 diabetes autoimmune diseases?. Diabetes 64 (2015), 1886–1897.
363. Tsai, S.W., Chan, Y.C., Liang, F., Hsu, C.Y., Lee, I.T., Brain-derived neurotrophic factor correlated with muscle strength in subjects undergoing stationary bicycle exercise training. J. Diabetes Complications 29 (2015), 367–371.
364. Tseng, Y.H., Kokkotou, E., Schulz, T.J., Huang, T.L., Winnay, J.N., Taniguchi, C.M., Tran, T.T., Suzuki, R., Espinoza, D.O., Yamamoto, Y., Ahrens, M.J., Dudley, A.T., Norris, A.W., Kulkarni, R.N., Kahn, C.R., New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature 454 (2008), 1000–1004.
365. Tumova, J., Andel, M., Trnka, J., Excess of free fatty acids as a cause of metabolic dysfunction in skeletal muscle. Physiol. Res.(October (8)), 2015.
366. Tuomi, T., Santoro, N., Caprio, S., Cai, M., Weng, J., Groop, L., The many faces of diabetes: a disease with increasing heterogeneity. Lancet 383 (2014), 1084–1094.
367. Tyrovolas, S., Koyanagi, A., Olaya, B., Ayuso-Mateos, J.L., Miret, M., Chatterji, S., Tobiasz-Adamczyk, B., Koskinen, S., Leonardi, M., Haro, J.M., The role of muscle mass and body fat on disability among older adults: a cross-national analysis. Exp. Gerontol. 69 (2015), 27–35.
368. Uaesoontrachoon, K., Yoo, H.J., Tudor, E.M., Pike, R.N., Mackie, E.J., Pagel, C.N., Osteopontin and skeletal muscle myoblasts: association with muscle regeneration and regulation of myoblast function in vitro. Int. J. Biochem. Cell. Biol. 40 (2008), 2303–2314.
369. Unger, R.H., Clark, G.O., Scherer, P.E., Orci, L., Lipid homeostasis, Lipotoxicity and the metabolic syndrome. Biochim. Biophys. Acta 1801 (2010), 209–214.
370. Vamvini, M.T., Aronis, K.N., Panagiotou, G., Huh, J.Y., Chamberland, J.P., Brinkoetter, M.T., Petrou, M., Christophi, C.A., Kales, S.N., Christiani, D.C., Mantzoros, C.S., Irisin mRNA and circulating levels in relation to other myokines in healthy and morbidly obese humans. Eur. J. Endocrinol. 169 (2013), 829–834.
371. Van Dyke, J.M., Smit-Oistad, I.M., Macrander, C., Krakora, D., Meyer, M.G., Suzuki, M., Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS). Exp. Neurol. 277 (2016), 275–282.
372. Vaughan, R.A., Gannon, N.P., Mermier, C.M., Conn, C.A., Irisin, a unique non-inflammatory myokine in stimulating skeletal muscle metabolism. J. Physiol. Biochem. 71 (2015), 679–689.
373. Venojärvi, M., Wasenius, N., Manderoos, S., Heinonen, O.J., Hernelahti, M., Lindholm, H., Surakka, J., Lindström, J., Aunola, S., Atalay, M., Eriksson, J.G., Nordic walking decreased circulating chemerin and leptin concentrations in middle-aged men with impaired glucose regulation. Ann. Med. 45 (2013), 162–170.
374. Versini, M., Jeandel, P.Y., Rosenthal, E., Shoenfeld, Y., Obesity in autoimmune diseases: not a passive bystander. Autoimmun. Rev. 13 (2014), 981–1000.
375. Vetrone, S.A., Montecino-Rodriguez, E., Kudryashova, E., Kramerova, I., Hoffman, E.P., Liu, S.D., Miceli, M.C., Spencer, M.J., Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta. J. Clin. Invest. 119 (2009), 1583–1594.
376. Vigelso, A., Prats, C., Ploug, T., Dela, F., Helge, J.W., Higher muscle content of perilipin 5 and endothelial lipase protein in trained than untrained middle-aged men. Physiol. Res.(October (8)), 2015.
377. Vilarrasa, N., Vendrell, J., Maravall, J., Broch, M., Estepa, A., Begia, A., Soler, J., Simon, I., Richart, C., Gomez, J.M., Distribution and determinants of adiponectin: resistin and ghrelin in a randomly selected healthy population. Clin. Endocrinol. 63 (2005), 329–335.
378. Voss, S.C., Nikolovski, Z., Bourdon, P.C., Alsayrafi, M., Schumacher, Y.O., The effect of cumulative endurance exercise on leptin and adiponectin and their role as markers to monitor training load. Biol. Sport 33 (2016), 23–28.
379. Walston, J.D., Connecting age-Related biological decline to frailty and late-Life vulnerability. Nestle Nutr. Inst. Workshop Ser. 83 (2015), 1–10.
380. Wang, Y., Liu, X., Hou, L., Wu, W., Zhao, S., Xiong, Y., Fibroblast growth factor 21 suppresses adipogenesis in pig intramuscular fat cells. Int. J. Mol. Sci., 17, 2015, E11.
381. Wannamethee, S.G., Atkins, J.L., Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity. Proc. Nutr. Soc. 74 (2015), 405–412.
382. Weisberg, S.P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R.L., Ferrante, A.W. Jr., Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112 (2003), 1796–1808.
383. Wensveen, F.M., Valentić, S., Šestan, M., Turk Wensveen, T., Polić, B., The Big Bang in obese fat: events initiating obesity-induced adipose tissue inflammation. Eur. J. Immunol. 45 (2015), 2446–2456.
384. Whittle, A.J., Carobbio, S., Martins, L., Slawik, M., Hondares, E., Vázquez, M.J., Morgan, D., Csikasz, R.I., Gallego, R., Rodriguez-Cuenca, S., Dale, M., Virtue, S., Villarroya, F., Cannon, B., Rahmouni, K., López, M., Vidal-Puig, A., BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions. Cell 149 (2012), 871–885.
385. Winer, S., Paltser, G., Chan, Y., Tsui, H., Engleman, E., Winer, D., Dosch, H.M., Obesity predisposes to Th17 bias. Eur. J. Immunol. 39 (2009), 2629–2635.
386. Winer, D.A., Winer, S., Shen, L., Wadia, P.P., Yantha, J., Paltser, G., Tsui, H., Wu, P., Davidson, M.G., Alonso, M.N., Leong, H.X., Glassford, A., Caimol, M., Kenkel, J.A., Tedder, T.F., McLaughlin, T., Miklos, D.B., Dosch, H.M., Engleman, E.G., B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat. Med. 17 (2011), 610–617.
387. Winer, D.A., Winer, S., Chng, M.H., Shen, L., Engleman, E.G., B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance. Cell. Mol. Life Sci. 71 (2014), 1033–1043.
388. Wronska, A., Kmiec, Z., Structural and biochemical characteristics of various white adipose tissue depots. Acta Physiol. (Oxf.) 205 (2012), 194–208.
389. Wu, D., Molofsky, A.B., Liang, H.E., Ricardo-Gonzalez, R.R., Jouihan, H.A., Bando, J.K., Chawla, A., Locksley, R.M., Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 332 (2011), 243–247.
390. Xiao, F., Tan, J.Z., Xu, X., Zhu, B.L., Fang, S., Wang, X.F., Increased osteopontin in muscle and serum from patients with idiopathic inflammatory myopathies. Clin. Exp. Rheumatol. 33 (2015), 399–404.
391. Xie, Q., Deng, Y., Huang, C., Liu, P., Yang, Y., Shen, W., Gao, P., Chemerin-induced mitochondrial dysfunction in skeletal muscle. J. Cell. Mol. Med. 19 (2015), 986–995.
392. Xin, C., Liu, J., Zhang, J., Zhu, D., Wang, H., Xiong, L., Lee, Y., Ye, J., Lian, K., Xu, C., Zhang, L., Wang, Q., Liu, Y., Tao, L., Irisin improves fatty acid oxidation and glucose utilization in type 2 diabetes by regulating the AMPK signaling pathway. Int. J. Obes. (Lond.) 40 (2016), 443–451.
393. Xu, H., Barnes, G.T., Yang, Q., Tan, G., Yang, D., Chou, C.J., Sole, J., Nichols, A., Ross, J.S., Tartaglia, L.A., Chen, H., Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112 (2003), 1821–1830.
394. Xu, W., Yu, L., Zhou, W., Luo, M., Resistin increases lipid accumulation and CD36 expression in human macrophages. Biochem. Biophys. Res. Commun. 351 (2006), 376–382.
395. Xu, X., Grijalva, A., Skowronski, A., van Eijk, M., Serlie, M.J., Ferrante, A.W. Jr., Obesity activates a program of lysosomal-dependent lipid metabolism in adipose tissue macrophages independently of classic activation. Cell. Metab. 18 (2013), 816–830.
396. Xu, L., Kitade, H., Ni, Y., Ota, T., Roles of chemokines and chemokine receptors in obesity-associated insulin resistance and nonalcoholic fatty liver disease. Biomolecules 5 (2015), 1563–1579.
397. Xu, M., Tchkonia, T., Ding, H., Ogrodnik, M., Lubbers, E.R., Pirtskhalava, T., White, T.A., Johnson, K.O., Stout, M.B., Mezera, V., Giorgadze, N., Jensen, M.D., LeBrasseur, N.K., Kirkland, J.L., JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), E6301–6310.
398. Yan, B., Shi, X., Zhang, H., Pan, L., Ma, Z., Liu, S., Liu, Y., Li, X., Yang, S., Li, Z., Association of serum irisin with metabolic syndrome in obese Chinese adults. PLoS One, 9, 2014, e94235.
399. Yao, L., Herlea-Pana, O., Heuser-Baker, J., Chen, Y., Barlic-Dicen, J., Roles of the chemokine system in development of obesity, insulin resistance, and cardiovascular disease. J. Immunol. Res., 2014, 2014, 181450.
400. Yao-Borengasser, A., Varma, V., Coker, R.H., Ranganathan, G., Phanavanh, B., Rasouli, N., Kern, P.A., Adipose triglyceride lipase expression in human adipose tissue and muscle Role in insulin resistance and response to training and pioglitazone. Metabolism 60 (2011), 1012–1020.
401. Ye, J., Beneficial metabolic activities of inflammatory cytokine interleukin 15 in obesity and type 2 diabetes. Front. Med. 9 (2015), 139–145.
402. You, J.S., Ji, H.I., Chang, K.J., Yoo, M.C., Yang, H.I., Jeong, I.K., Kim, K.S., Serum osteopontin concentration is decreased by exercise-induced fat loss but is not correlated with body fat percentage in obese humans. Mol. Med. Rep. 8 (2013), 579–584.
403. Youm, Y.H., Horvath, T.L., Mangelsdorf, D.J., Kliewer, S.A., Dixit, V.D., Prolongevity hormone FGF21 protects against immune senescence by delaying age-related thymic involution. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), 1026–1031.
404. Youn, J.Y., Cai, H., Fueling up skeletal muscle to reduce obesity A TrkB story. Chem. Biol. 22 (2015), 311–312.
405. Zamboni, M., Mazzali, G., Zoico, E., Harris, T.B., Meigs, J.B., DiFrancesco, V., Fantin, F., Bissoli, L., Bosello, O., Health consequences of obesity in the elderly: a review of four unresolved questions. Int. J. Obes. (Lond.) 29 (2005), 1011–1029.
406. Zamboni, M., Mazzali, G., Fantin, F., Rossi, A., Di Francesco, V., Sarcopenic obesity: a new category of obesity in the elderly. Nutr. Metab. Cardiovasc. Dis. 18 (2008), 388–395.
407. Zanotti, S., Gibertini, S., Di Blasi, C., Cappelletti, C., Bernasconi, P., Mantegazza, R., Morandi, L., Mora, M., Osteopontin is highly expressed in severely dystrophic muscle and seems to play a role in muscle regeneration and fibrosis. Histopathology 59 (2011), 1215–1228.
408. Zeyda, M., Gollinger, K., Todoric, J., Kiefer, F.W., Keck, M., Aszmann, O., Prager, G., Zlabinger, G.J., Petzelbauer, P., Stulnig, T.M., Osteopontin is an activator of human adipose tissue macrophages and directly affects adipocyte function. Endocrinology 152 (2011), 2219–2227.
409. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., Friedman, J.M., Positional cloning of the mouse obese gene and its human homologue. Nature 372 (1994), 425–432.
410. Zhang, C., McFarlane, C., Lokireddy, S., Masuda, S., Ge, X., Gluckman, P.D., Sharma, M., Kambadur, R., Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice. Diabetologia 55 (2012), 183–193.
411. Zhang, Y., Yang, P., Cui, R., Zhang, M., Li, H., Qian, C., Sheng, C., Qu, S., Bu, L., Eosinophils reduce chronic inflammation in adipose tissue by secreting Th2 cytokines and promoting M2 macrophages polarization. Int. J. Endocrinol., 2015, 2015, 565760.
412. Zhang, C., Ding, Z., Lv, G., Li, J., Zhou, P., Zhang, J., Lower irisin level in patients with type 2 diabetes mellitus: a case-control study and meta-analysis. J. Diabetes. 8 (2016), 56–62.
413. Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A.C., Ding, H., Giorgadze, N., Palmer, A.K., Ikeno, Y., Hubbard, G.B., Lenburg, M., O'Hara, S.P., LaRusso, N.F., Miller, J.D., Roos, C.M., Verzosa, G.C., LeBrasseur, N.K., Wren, J.D., Farr, J.N., Khosla, S., Stout, M.B., McGowan, S.J., Fuhrmann-Stroissnigg, H., Gurkar, A.U., Zhao, J., Colangelo, D., Dorronsoro, A., Ling, Y.Y., Barghouthy, A.S., Navarro, D.C., Sano, T., Robbins, P.D., Niedernhofer, L.J., Kirkland, J.L., The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell 14 (2015), 644–658.
414. Ziaaldini, M.M., Koltai, E., Csende, Z., Goto, S., Boldogh, I., Taylor, A.W., Radak, Z., Exercise training increases anabolic and attenuates catabolic and apoptotic processes in aged skeletal muscle of male rats. Exp. Gerontol. 67 (2015), 9–14.
415. Zindl, C.L., Lai, J.F., Lee, Y.K., Maynard, C.L., Harbour, S.N., Ouyang, W., Chaplin, D.D., Weaver, C.T., IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 12761–12768.
416. Zlotnikov-Klionsky, Y., Nathansohn-Levi, B., Shezen, E., Rosen, C., Kagan, S., Bar-On, L., Jung, S., Shifrut, E., Reich-Zeliger, S., Friedman, N., Aharoni, R., Arnon, R., Yifa, O., Aronovich, A., Reisner, Y., Perforin-positive dendritic cells exhibit an immuno-regulatory role in metabolic syndrome and autoimmunity. Immunity 43 (2015), 776–787.